Other spirochaetal diseases, including avohilmo

AB1_OTHER_SPIROCHAETAL_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A65-A69 Hospital discharge: ICD-10 — A65-A69 Hospital discharge: ICD-9 — 104\|08[7-7] Hospital discharge: ICD-8 — 08[8-9] Cause of death: ICD-10 — A65-A69 Cause of death: ICD-9 — 104\|08[7-7] Cause of death: ICD-8 — 08[8-9] 3 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints AB1_SYPHILIS_NONVENEREAL AB1_YAWNS AB1_PINTA AB1_RELAP_FEVER AB1_SPIROCHE_OTHER AB1_LYME	18288
6. Filter based on genotype QC (FinnGen only)	16731

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF13

NAME	AB1_OTHER_SPIROCHAETAL_WIDE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	AB1_SYPHILIS_NONVENEREAL\|AB1_YAWNS\|AB1_PINTA\|AB1_RELAP_FEVER\|AB1_SPIROCHE_OTHER\|AB1_LYME
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A6[5-9]
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A6[5-9]
HD_ICD_9	104\|08[7-7]
HD_ICD_8	08[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A6[5-9]
COD_ICD_9	104\|08[7-7]
COD_ICD_8	08[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other spirochaetal diseases, including avohilmo based on the number of shared cases.

Similar with more cases:

Certain infectious and parasitic diseases, including avohilmo

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16731	10510	6221
Unadjusted period prevalence (%)	3.40	3.73	2.85
Median age at first event (years)	63.24	62.24	64.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17342: Matched controls
173419

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.4

307.7

1089

2602

S12

ICPC

Insect bite/sting

7.4

307.7

4412

7596

J01CA04

ATC

amoxicillin; systemic

3.9

307.7

15760

124475

A69.2

ICD-10 Finland

Lyme disease

198278.4

307.7

16679

M01.2*A69.2

ICD-10 Finland

Arthritis in Lyme disease

116.8

272.8

139

S29

ICPC

Skin symptom/complaint other

1.7

181.8

3869

24521

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

354.9

175.7

177

S73

ICPC

Pediculosis/skin infestation other

11.5

170.4

176

154

S72

ICPC

Scabies/other acariasis

4.8

158.9

363

769

J01AA02

ATC

doxycycline; systemic

1.6

149.9

13340

116565

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

135.0

3872

26231

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

126.1

3747

25536

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

1217.6

124.1

121

TAB00

NOMESCO Finland

Lumbar puncture

2.3

108.5

841

3720

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

95.4

3255

22692

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

94.8

2310

14892

S13

ICPC

Animal/human bite

2.3

89.3

672

2931

M25.5

ICD-10 Finland

Pain in joint

1.4

87.5

5595

43888

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

87.0

1362

7763

A98

ICPC

Health maint/preventive medicine

2.8

86.9

16985

163719

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

86.2

2982

20800

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

84.6

680

3050

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

81.3

4977

38636

1048A

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]

+∞

81.3

SPAT1262

SPAT

Handing over of treatment supplies

0.5

80.9

1079

18886

SPAT1152

SPAT

Removal of foreign body from under the skin

2.7

78.8

445

1697

103

Kela drug reimbursment

Diabetes, insulin-treated

0.6

76.9

2117

30923

Z2221

NOMESCO Finland

Medical doctor

1.4

76.0

4205

32006

S08

ICPC

Skin colour change

1.9

72.8

926

4933

B88.0

ICD-10 Finland

Other acariasis

6.4

72.1

119

187

S06

ICPC

Rash localized

1.9

70.4

940

5087

L57.0

ICD-10 Finland

Actinic keratosis

1.6

69.1

1580

9973

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

66.2

8116

69426

A66.1

ICD-10 Finland

Multiple papillomata and wet crab yaws

+∞

61.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

61.2

2096

29494

A69.10

ICD-10 Finland

Acute necrotizing ulcerative gingivitis (ANUG)

+∞

59.4

A68.9

ICD-10 Finland

Relapsing fever, unspecified

+∞

58.4

N73

ICPC

Neurological infection other

18.4

57.7

A10BA02

ATC

metformin; oral

0.7

56.4

2459

33171

205

Kela drug reimbursment

Chronic hypertension

0.7

54.0

1969

27471

SPAT1324

SPAT

Screening procedure

0.6

53.5

1330

20064

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

52.0

1965

27258

C03CA01

ATC

furosemide; systemic

0.7

50.9

2302

30949

G51.0

ICD-10 Finland

Bell palsy

2.2

50.1

426

1955

A69.9

ICD-10 Finland

Spirochaetal infection, unspecified

+∞

50.0

M04AB01

ATC

probenecid; oral

10.6

49.6

D22

ICD-10 Finland

Melanocytic naevi

1.7

49.2

876

5162

R83

ICPC

Respiratory infection other

1.3

49.1

3910

31154

M01AH05

ATC

etoricoxib; oral

1.3

48.9

10271

92503

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

48.9

3582

28194

D19

ICPC

Teeth/gum symptom/complaint

1.3

48.4

4903

40371

T90

ICPC

Diabetes non-insulin dependent

0.7

47.8

2165

29146

S21

ICPC

Skin texture symptom/complaint

1.4

46.8

2361

17496

M79.6

ICD-10 Finland

Pain in limb

1.3

46.4

7109

61527

L548, A692,

ICD-10 Finland

+∞

45.8

Z01.7

ICD-10 Finland

Laboratory examination

1.4

45.4

2600

19670

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

45.4

3998

32250

Z71.8

ICD-10 Finland

Other specified counselling

1.3

45.2

5363

44961

WX725

NOMESCO Finland

Noninvasive ventilation

0.4

44.4

217

5494

A10AE04

ATC

insulin glargine; parenteral

0.5

42.3

511

9314

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.7

41.4

2281

29844

J01FA10

ATC

azithromycin; systemic

1.2

40.8

9121

81887

H02

ICPC

Hearing complaint

1.4

40.8

2126

15815

R06AX27

ATC

desloratadine; oral

1.3

40.3

4413

36518

WW200, ,

SPAT

1.3

40.1

4692

39142

WX720

NOMESCO Finland

Own respiration

0.4

39.9

177

4677

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

38.3

5479

46736

H02AB07

ATC

prednisone; oral

1.4

37.1

1878

13886

D01AE16

ATC

amorolfine; topical

1.4

36.1

1629

11807

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

0.7

34.9

1282

18015

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

34.8

411

2133

A23

ICPC

Risk factor NOS

1.4

34.7

1420

10109

R01AD09

ATC

mometasone; nasal

1.2

34.5

7049

62253

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

34.4

1073

7238

A97

ICPC

No disease

1.3

33.9

2995

24032

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

33.7

729

4521

A10AC01

ATC

insulin (human); parenteral

0.5

33.5

309

6143

GD1AA, ,

SPAT

1.3

33.5

2405

18756

WX704

NOMESCO Finland

Intubation

0.6

33.4

508

8691

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

32.5

3339

27293

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

32.4

351

6621

SPAT1254

SPAT

Administration of medicine

0.7

32.3

1015

14705

J01DB01

ATC

cefalexin; oral

1.3

32.0

13519

127982

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

31.7

818

5290

D01BA02

ATC

terbinafine; oral

1.3

31.3

3691

30654

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.6

31.1

670

10517

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

31.0

1884

14322

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

30.9

4148

34948

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

30.9

1549

11417

A10AB05

ATC

insulin aspart; parenteral

0.5

30.7

396

7097

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

30.7

718

11066

H10

ICD-10 Finland

Conjunctivitis

1.5

30.5

1038

7125

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

30.5

3748

31265

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

30.4

964

13944

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.4

1550

11458

S82

ICPC

Naevus/mole

1.3

30.3

2087

16159

H93.1

ICD-10 Finland

Tinnitus

1.5

30.2

1029

7066

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

30.2

708

4479

EB1AA, ,

SPAT

1.5

30.1

930

6257

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

0.5

29.8

264

5322

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.4

29.7

203

851

R01AD08

ATC

fluticasone; nasal

1.2

29.7

4226

35808

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

29.5

4306

50195

D06BB10

ATC

imiquimod; topical

1.6

29.4

722

4617

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

29.3

1434

10524

A66.3

ICD-10 Finland

Hyperkeratosis of yaws

+∞

29.2

C01CA24

ATC

epinephrine; parenteral

1.5

29.0

862

5752

V18

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident

3.1

28.4

119

388

R05

ICD-10 Finland

Cough

1.3

28.1

3204

26456

TPH07

NOMESCO Finland

Cathetrisation of artery

0.7

28.0

795

11765

Z51.5

ICD-10 Finland

Palliative care

0.6

27.7

484

7992

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

27.6

738

11054

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.7

27.5

1277

17282

SPAT1222

SPAT

Counselling/guidance promoting independent living

0.7

27.2

1073

14932

A69

ICD-10 Finland

Other spirochaetal infections

+∞

27.1

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

27.0

1265

9211

R51.80

ICD-10 Finland

Headache

1.3

26.9

2222

17618

SPAT1263

SPAT

Sampling

0.8

26.9

4700

53944

R4110

NOMESCO Finland

Physiotherapy

1.2

26.9

4014

34121

L17

ICPC

Foot/toe symptom/complaint

1.2

26.7

4656

40201

R74

ICPC

Upper respiratory infection acute

1.2

26.6

4915

42674

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

26.6

6421

57159

A28

ICPC

Limited function/disability NOS

0.7

26.4

1317

17635

I50.0

ICD-10 Finland

Congestive heart failure

0.5

26.2

256

4996

J05AB11

ATC

valaciclovir; oral

1.3

26.2

2100

16580

X58

ICD-10 Finland

Exposure to other specified factors

1.3

26.2

2099

16572

130

Kela drug reimbursment

Malignant tumour

0.6

26.1

522

8340

M79.1

ICD-10 Finland

Myalgia

1.3

26.0

2162

17153

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

25.8

4576

39547

R52.9

ICD-10 Finland

Pain, unspecified

1.4

25.5

1503

11354

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.4

25.5

175

3862

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

25.5

492

7930

S18

ICPC

Laceration/cut

1.2

25.4

7197

64880

B35.1

ICD-10 Finland

Tinea unguium

1.5

25.3

956

6697

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

25.2

1765

13681

HA1RA, ,

SPAT

1.6

25.1

674

4400

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

25.0

1215

8897

M01.2

ICD-10 Finland

Arthritis in Lyme disease

38.9

24.8

W86

ICD-10 Finland

Exposure to other specified electric current

3.2

24.8

299

SPAT1097

SPAT

Recording of ECG

0.7

24.5

1124

15257

OAB50, ,

SPAT

0.6

24.2

557

8623

SDA03

NOMESCO Finland

Periodontal treatment

1.2

24.2

6314

56445

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

24.2

3440

29043

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

24.0

609

3924

A66.2

ICD-10 Finland

Other early skin lesions of yaws

+∞

24.0

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

4.5

24.0

126

M03BX02

ATC

tizanidine; oral

1.2

23.9

9841

91342

H81

ICPC

Excessive ear wax

1.3

23.9

2351

19044

M01AE02

ATC

naproxen; oral, rectal

1.2

23.8

8647

79430

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

23.7

399

6651

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

23.6

7484

67955

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

23.4

2868

23822

F29

ICPC

Eye symptom/complaint other

1.3

23.3

1536

11795

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

23.2

1382

10454

L08

ICPC

Shoulder symptom/complaint

1.2

23.0

3426

29038

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

22.9

1119

8199

PH2AE, ,

SPAT

1.9

22.9

311

1693

0879X

ICD-9 Finland

Relapsing fever, unspecified

+∞

22.9

A10BB12

ATC

glimepiride; oral

0.5

22.9

259

4822

G04CA01

ATC

alfuzosin; oral

1.3

22.7

1360

10296

A06AD11

ATC

lactulose; oral

0.7

22.6

989

13537

N05AX08

ATC

risperidone; systemic

0.6

22.5

438

7046

N02AA05

ATC

oxycodone; systemic

0.8

22.3

1508

19348

R51

ICD-10 Finland

Headache

1.5

22.0

762

5245

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

21.9

1297

9798

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

3.9

21.8

162

A10BH01

ATC

sitagliptin; oral

0.7

21.7

628

9269

J20

ICD-10 Finland

Acute bronchitis

1.3

21.4

1460

11264

L30

ICD-10 Finland

Other dermatitis

1.8

21.0

330

1879

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

20.9

1927

15464

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

0.7

20.8

558

8368

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

20.8

1339

10243

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

20.7

2303

18895

Z01.2

ICD-10 Finland

Dental examination

1.2

20.6

7243

66050

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

20.6

459

2869

K08.80

ICD-10 Finland

Toothache NOS

1.3

20.6

1265

9608

UDC00

NOMESCO Finland

Ear microscopy

0.6

20.6

460

7171

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

20.5

620

4156

F38

ICPC

Eye, Other laboratory test NEC

1.9

20.3

243

1271

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

20.2

983

7198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

20.2

790

5570

N05AA02

ATC

levomepromazine; systemic

0.5

20.1

147

3163

R01AD58

ATC

fluticasone, combinations; nasal

1.2

20.0

3634

31348

SPAT1301

SPAT

No procedures

0.8

19.9

3225

37532

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

0.5

19.8

184

3642

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

19.7

1565

12317

TPH04

NOMESCO Finland

Cathetrisation of vein

0.8

19.7

2158

26133

G63.0

ICD-10 Finland

Polyneuropathy in infectious and parasitic diseases classified elsewhere

28.9

19.6

H01.0

ICD-10 Finland

Blepharitis

1.4

19.6

944

6902

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

19.4

1212

9227

EB1SA, ,

SPAT

1.5

19.4

689

4769

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

19.3

702

4880

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

19.2

3993

34838

A10AE05

ATC

insulin detemir; parenteral

0.6

19.2

248

4440

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

19.1

1154

8742

L15

ICPC

Knee symptom/complaint

1.2

19.0

3749

32556

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

18.8

7007

64021

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

18.6

808

5802

L01

ICPC

Neck symptom/complaint

1.2

18.5

2335

19411

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

18.3

343

5568

L03

ICPC

Low back symptom/complaint

1.2

18.2

4314

38029

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

18.2

292

1675

M54

ICD-10 Finland

Dorsalgia

1.3

18.2

1703

13686

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

18.1

1339

10442

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

17.9

3327

28721

SPAT1304

SPAT

Counselling and guidance related to ageing

0.6

17.9

341

5511

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

17.7

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

17.7

14891

144421

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

17.6

507

3364

NG2AA

NOMESCO Finland

Patella X-ray examination

1.6

17.6

375

2322

H92.0

ICD-10 Finland

Otalgia

1.4

17.5

850

6223

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

17.4

5361

48212

N05AH03

ATC

olanzapine; systemic

0.6

17.4

369

5820

EBA15

NOMESCO Finland

Extraction of multiple teeth

0.5

17.3

170

3306

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

17.1

396

6127

M67.4

ICD-10 Finland

Ganglion

1.4

17.1

923

6872

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

17.1

844

11350

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

17.1

1482

L13

ICPC

Hip symptom/complaint

1.2

17.0

2775

23653

A04AA02

ATC

granisetron; systemic, transdermal

0.6

17.0

424

6453

SPAT1100

SPAT

Long-term monitoring of blood pressure

0.6

17.0

330

5308

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

16.9

177

3371

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

16.8

4786

42759

SPAT1193

SPAT

Pap smear

0.7

16.8

621

8762

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

16.7

784

5710

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.8

16.5

233

1287

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

16.5

3695

32379

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

16.5

587

4067

R42

ICD-10 Finland

Dizziness and giddiness

1.2

16.4

3139

27140

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

16.3

391

6001

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.8

16.3

249

1409

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

16.3

1418

17657

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

16.2

580

4022

R00.2

ICD-10 Finland

Palpitations

1.3

16.1

1086

8355

-31

ICPC

Medical examin/health eval partial

0.6

16.1

392

5994

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

15.9

1548

12485

G44.2

ICD-10 Finland

Tension-type headache

1.2

15.7

1874

15474

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

15.6

4334

38601

A10BB01

ATC

glibenclamide; oral

0.4

15.6

1802

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

15.6

362

5596

A66.9

ICD-10 Finland

Yaws, unspecified

+∞

15.6

A69.0

ICD-10 Finland

Necrotizing ulcerative stomatitis

+∞

15.6

TK800

NOMESCO Finland

Hemodialysis

0.3

15.6

1515

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

15.6

1181

9236

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

160.1

15.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.6

15.5

235

4019

WX002

NOMESCO Finland

Sedation and analgesia

1.2

15.4

2500

21279

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

0.8

15.4

1453

17933

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.0

15.4

154

759

OAB95, ,

SPAT

1.3

15.4

1016

7796

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.4

2739

23515

R06AX22

ATC

ebastine; oral

1.2

15.3

2358

19970

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

12.3

15.3

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

15.2

1300

10321

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

15.2

1633

WX110, ,

SPAT

1.4

15.2

728

5318

N30

ICD-10 Finland

Cystitis

1.3

15.2

1089

8453

A10BK03

ATC

empagliflozin; oral

0.7

15.2

821

10892

L53.8

ICD-10 Finland

Other specified erythematous conditions

3.1

15.1

196

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.7

15.0

242

1392

SPAT1360

SPAT

Extensive global examination

1.4

15.0

824

6152

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.8

15.0

995

12828

J18.9

ICD-10 Finland

Pneumonia, unspecified

0.8

14.9

2373

27767

H02AB02

ATC

dexamethasone; systemic

0.8

14.9

989

12746

M01AB05

ATC

diclofenac; systemic, rectal

1.1

14.8

10201

96535

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.5

14.7

160

3007

HARJA, ,

NOMESCO Finland

3.2

14.7

179

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.6

14.7

346

5327

SPAT1229

SPAT

Assessment of need for aid

0.7

14.7

455

6627

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

14.6

1345

OAA67, ,

SPAT

1.2

14.6

2273

19262

SPAT1245

SPAT

Provision of support and information to patient’s family members

0.5

14.6

134

2659

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

F45.8

ICD-10 Finland

Other somatoform disorders

1.3

14.6

850

6406

M75

ICD-10 Finland

Shoulder lesions

1.4

14.5

574

4056

HMAK, ,

NOMESCO Finland

0.8

14.5

939

12152

CS494

NOMESCO Finland

Other visual field testing

1.6

14.5

318

1986

N17.9

ICD-10 Finland

Acute renal failure, unspecified

0.5

14.4

176

3198

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.4

14.4

583

4141

L12

ICPC

Hand/finger symptom/complaint

1.2

14.3

2431

20775

H60

ICD-10 Finland

Otitis externa

1.4

14.3

677

4940

R21

ICPC

Throat symptom/complaint

1.2

14.2

2884

25028

R35

ICD-10 Finland

Polyuria

1.3

14.2

821

6181

NH3AA, ,

SPAT

1.4

14.1

728

5383

J01MA01

ATC

ofloxacin; systemic

1.3

14.0

921

7065

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

13.9

265

4283

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

13.9

147

2788

N18.8

ICD-10 Finland

Other chronic renal failure

0.4

13.8

1527

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

13.8

790

5941

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

13.7

2734

23679

G04CB01

ATC

finasteride; oral

1.3

13.7

992

7707

J01

ICD-10 Finland

Acute sinusitis

1.4

13.7

730

5426

A10AA02, ,

ATC

0.5

13.6

100

2141

D01

ICPC

Abdominal pain/cramps general

1.2

13.6

1669

13808

N17

ICPC

Vertigo/dizziness

1.2

13.6

1664

13766

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

1.9

13.6

173

928

NG1BG, ,

SPAT

1.4

13.6

504

3524

A02BC04

ATC

rabeprazole; oral

1.3

13.5

1153

9156

SPAT1395

SPAT

Health check-up of persons outside student and working life

0.4

13.5

1911

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

13.5

1808

15098

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.4

13.3

1456

R06AE07

ATC

cetirizine; oral

1.1

13.3

6503

60073

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

0.4

13.2

1454

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

13.2

6436

59429

M15

ICD-10 Finland

Polyarthrosis

1.4

13.2

640

4690

S04

ICPC

Lump/swelling localized

1.2

13.2

1473

12069

SPAT1377

SPAT

Polysomnography

0.5

13.1

151

2789

R01BA52

ATC

pseudoephedrine, combinations; oral

1.1

13.1

4262

38313

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

13.1

7835

73248

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

0.6

13.0

232

3808

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

13.0

1724

14373

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

13.0

1205

14914

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

13.0

389

5701

J05AB01

ATC

aciclovir; systemic

1.2

13.0

2976

26065

WX723

NOMESCO Finland

CPAP therapy

0.6

13.0

263

4185

L90.4

ICD-10 Finland

Acrodermatitis chronica atrophicans

10.9

13.0

K30

ICD-10 Finland

Functional dyspepsia

1.2

13.0

1541

12707

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

13.0

706

5268

HA1AE, ,

SPAT

1.5

12.9

425

2902

A10BH05

ATC

linagliptin; oral

0.6

12.9

257

4109

A10BJ06

ATC

semaglutide; parenteral

0.7

12.9

351

5244

Z00.0

ICD-10 Finland

General medical examination

1.2

12.9

2576

22305

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

12.9

441

3036

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.4

12.8

1844

H02AB04

ATC

methylprednisolone; systemic

1.2

12.7

1859

15652

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

12.7

3030

26618

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

12.7

200

3383

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

12.7

2554

22129

B01AB10

ATC

tinzaparin; parenteral

0.8

12.7

968

12261

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

12.6

994

7811

H61.2

ICD-10 Finland

Impacted cerumen

1.3

12.6

854

6577

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

12.5

1935

16374

J37.0

ICD-10 Finland

Chronic laryngitis

1.5

12.5

406

2766

A67.0

ICD-10 Finland

Primary lesions of pinta

+∞

12.5

A69.8

ICD-10 Finland

Other specified spirochaetal infections

+∞

12.5

A02BC05

ATC

esomeprazole; systemic

1.1

12.5

5890

54219

J02AC02

ATC

itraconazole; systemic

1.2

12.5

2364

20379

P72

ICPC

Schizophrenia

0.4

12.4

1337

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.6

12.4

261

1615

N05AD01

ATC

haloperidol; systemic

0.5

12.4

2041

I50.1

ICD-10 Finland

Left ventricular failure

0.6

12.4

192

3262

A10AB01

ATC

insulin (human); parenteral

0.5

12.4

132

2493

C09AA05

ATC

ramipril; oral

0.8

12.4

2329

26903

H29

ICPC

Ear symptom/complaint other

1.2

12.3

1621

13503

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.2

12.3

1348

11018

OAB43, ,

SPAT

1.1

12.3

4147

37352

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.7

12.3

327

4903

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

12.3

1211

9782

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

12.3

4826

52840

E66.01

ICD-10 Finland

Obesity due to excess calories

0.8

12.3

807

10419

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

12.3

113

2233

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.6

12.3

315

2044

C03DA01

ATC

spironolactone; oral

0.8

12.2

950

12009

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.3

12.2

1252

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

12.2

960

12112

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

12.2

1408

11576

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.2

12.1

1294

10543

XF402

NOMESCO Finland

ECG with work load test

1.2

12.1

1256

10200

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.4

12.1

454

3180

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.5

12.1

419

2893

R03BA02

ATC

budesonide; inhalant

1.2

12.0

2363

20428

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

12.0

930

7295

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

0.2

12.0

508

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.8

12.0

178

1003

R07.3

ICD-10 Finland

Other chest pain

1.2

12.0

1334

10924

NE1AA, ,

SPAT

1.7

11.9

234

1424

J01MA06

ATC

norfloxacin; oral

1.2

11.9

1590

13266

R52.2

ICD-10 Finland

Other chronic pain

1.4

11.9

462

3260

M23

ICD-10 Finland

Internal derangement of knee

1.5

11.9

309

2012

A06AC51

ATC

ispaghula, combinations; oral

1.4

11.8

580

4257

R01AD12

ATC

fluticasone furoate; nasal

1.1

11.8

4480

40642

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

11.8

1484

12307

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

11.7

1488

MAX99

NOMESCO Finland

Assistance to normal delivery

1.3

11.7

688

5195

A10AE06

ATC

insulin degludec; parenteral

0.6

11.7

177

3022

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

11.6

6287

58285

S59

ICPC

Skin, Other therap proced/minor surg NEC

1.6

11.6

265

1674

N05AF03

ATC

chlorprothixene; systemic

0.5

11.6

2004

A06AC01

ATC

ispaghula (psylla seeds); oral

1.1

11.5

3608

32305

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.6

11.5

221

3559

R50.9

ICD-10 Finland

Fever, unspecified

1.2

11.5

1925

16411

A84.8

ICD-10 Finland

Other tick-borne viral encephalitis

5.7

11.5

A10BD07

ATC

metformin and sitagliptin; systemic

0.6

11.5

223

3578

H22.0*A69.2

ICD-10 Finland

Iridocyclitis in Lyme disease

120.1

11.4

M77.4

ICD-10 Finland

Metatarsalgia

1.3

11.4

795

6151

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.6

11.4

178

3013

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

11.3

3644

32689

D23

ICD-10 Finland

Other benign neoplasms of skin

1.6

11.3

287

1859

M01AX05

ATC

glucosamine; oral

1.2

11.2

2370

20601

XQ855

NOMESCO Finland

Skin temperature measurement

2.8

11.2

204

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

11.2

1129

9141

SPAT1139

SPAT

Nutrition survey

0.6

11.2

144

2570

EBA00

NOMESCO Finland

Extraction of tooth

0.9

11.2

4336

47590

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

11.2

2926

25858

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

11.2

7955

84295

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

2.4

11.2

322

J45

ICD-10 Finland

Asthma

1.2

11.2

1365

11286

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

11.1

225

3579

LX2A3, ,

SPAT

0.5

11.1

135

2450

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.5

11.1

113

2163

XF640, ,

NOMESCO Finland

1.6

11.1

276

1781

SPAT1079

SPAT

Echocardiography

0.2

11.0

833

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

11.0

1079

8713

N05AH02

ATC

clozapine; systemic

0.4

11.0

1230

C10AA01

ATC

simvastatin; oral

0.9

10.9

4489

49107

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

0.5

10.9

1844

D07AD01

ATC

clobetasol; topical

1.2

10.9

2287

19865

H02AB06

ATC

prednisolone; systemic

1.1

10.9

6893

64396

H91.1

ICD-10 Finland

Presbycusis

1.3

10.8

649

4917

J02AC01

ATC

fluconazole; systemic

1.1

10.8

5746

53152

B01AF01

ATC

rivaroxaban; oral

1.2

10.8

1570

13206

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

2.6

10.8

237

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

0.7

10.8

274

4145

A11

ICPC

Chest pain NOS

1.3

10.8

1089

8822

SPAT1279

SPAT

Preparation of immediate hospitalisation

0.2

10.8

472

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

1.5

10.7

332

2243

N05BA06

ATC

lorazepam; systemic, sublingual

0.7

10.7

282

4237

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

0.2

10.7

454

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

10.7

766

5946

L29

ICPC

Musculoskeletal sympt/complt other

1.2

10.7

1161

9477

R03BC03

ATC

nedocromil; inhalant

1.3

10.7

826

6476

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

10.7

1435

17099

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

10.7

1422

11860

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

10.7

1761

20587

ZY010, ,

SPAT

1.7

10.6

183

1077

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.5

10.6

1634

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

10.6

219

3463

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

10.6

1314

10883

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

10.5

831

6535

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

10.5

1090

13327

QBE99, ,

SPAT

2.0

10.5

115

589

R53

ICD-10 Finland

Malaise and fatigue

1.1

10.5

3330

29823

A49.9

ICD-10 Finland

Bacterial infection, unspecified

0.8

10.5

862

10821

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

10.5

865

6843

A66

ICD-10 Finland

Yaws

+∞

10.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.9

10.4

2402

27337

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

10.4

185

3029

M19

ICD-10 Finland

Other arthrosis

1.5

10.4

271

1768

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

10.4

717

5543

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.1

10.4

6799

63593

Z3226

NOMESCO Finland

Physiotherapist

1.2

10.3

2263

19720

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

10.3

1630

13814

K58

ICD-10 Finland

Irritable bowel syndrome

1.5

10.3

318

2150

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

1.8

10.3

142

785

B35.3

ICD-10 Finland

Tinea pedis

1.3

10.2

569

4263

OAB47, ,

SPAT

0.7

10.2

327

4728

U02

ICPC

Urinary frequency/urgency

1.2

10.2

2001

17280

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.3

10.2

795

NG1AA, ,

SPAT

1.2

10.1

1056

8583

K03.66

ICD-10 Finland

Tooth plaque

1.3

10.1

983

7926

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

10.0

506

6781

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

10.0

1062

J01AA04

ATC

lymecycline; systemic

1.2

10.0

1624

13800

J01FA09

ATC

clarithromycin; systemic

1.1

10.0

4362

39852

L19

ICPC

Muscle symptom/complaint NOS

1.5

10.0

351

2435

Z37.0

ICD-10 Finland

Single live birth

1.3

10.0

746

5829

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.0

9.9

106

538

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.4

9.8

380

2682

SPAT1131

SPAT

Colonoscopy

0.6

9.8

147

2512

R23

ICD-10 Finland

Other skin changes

1.8

9.8

150

855

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

9.8

414

2969

A12BA01

ATC

potassium chloride; oral

0.6

9.8

140

2421

K59.0

ICD-10 Finland

Constipation

1.3

9.8

646

4964

N05AC02

ATC

thioridazine; oral

0.4

9.8

1336

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

0.5

9.7

1502

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

9.7

2508

22121

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

9.7

392

2788

H36.01

ICD-10 Finland

Diabetic maculopathy

0.3

9.7

834

SFB40

NOMESCO Finland

Filling of four surfaces reproduced outside mouth

2.1

9.7

421

QAE99, ,

SPAT

1.9

9.7

124

669

A10AB04

ATC

insulin lispro; parenteral

0.6

9.7

136

2365

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

9.7

458

3347

QX3HE, ,

SPAT

1.5

9.7

288

1933

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

9.7

773

6090

TUPEI, ,

NOMESCO Finland

1.4

9.7

415

2984

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.7

514

3827

QCE99, ,

SPAT

2.8

9.6

164

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

9.6

877

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

9.6

648

4992

N04AA02

ATC

biperiden; systemic

0.4

9.6

1329

U07

ICPC

Urine symptom/complaint other

1.2

9.6

1070

8764

A41.9

ICD-10 Finland

Sepsis, unspecified

0.6

9.6

154

2583

H00.00

ICD-10 Finland

Hordeolum

1.3

9.5

558

4214

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

9.5

675

5236

R07.0

ICD-10 Finland

Pain in throat

1.3

9.5

907

7299

N01

ICPC

Headache

1.2

9.5

1397

11762

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

1.7

9.5

181

1096

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

9.5

1293

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.4

9.5

376

2667

R12

ICD-10 Finland

Heartburn

1.2

9.4

1092

8979

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.4

1630

H58.8*A69.2

ICD-10 Finland

Ophthalmopathy in Lyme disease

+∞

9.4

A66.0

ICD-10 Finland

Initial lesions of yaws

+∞

9.4

AN1

Coronary angiography

0.8

9.4

734

9268

S01

ICPC

Pain/tenderness of skin

1.3

9.3

563

4271

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

9.3

2435

21498

R01BA01

ATC

phenylpropanolamine; oral

1.3

9.3

616

4739

EBA05, ,

SPAT

1.6

9.3

193

1196

G04BD12

ATC

mirabegron; oral

1.2

9.2

1493

12679

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

9.2

1633

A91

ICPC

Abnormal result investigation NOS

1.3

9.2

642

4969

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.8

9.2

138

782

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.5

9.2

1804

K05.31

ICD-10 Finland

Periodontitis pronounced

0.8

9.2

997

12137

M54.5

ICD-10 Finland

Low back pain

1.1

9.2

5292

49070

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

0.7

9.1

492

6528

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

9.1

1396

11797

D06BB03

ATC

aciclovir; topical

1.3

9.1

541

4096

C09BA02

ATC

enalapril and diuretics; systemic

0.8

9.1

526

6909

A84.9

ICD-10 Finland

Tick-borne viral encephalitis, unspecified

7.7

9.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

9.1

856

6884

C09AA02

ATC

enalapril; systemic

0.8

9.0

1671

19366

A26.0

ICD-10 Finland

Cutaneous erysipeloid

8.3

9.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.8

9.0

702

8871

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.2

9.0

1188

9897

A10AD05

ATC

insulin aspart; parenteral

0.3

9.0

860

R053, ,

ICD-10 Finland

1.4

8.9

426

3120

DAX08

NOMESCO Finland

Fitting of hearing aid

1.3

8.9

622

4818

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

8.9

633

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.7

8.9

377

5186

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

8.9

752

5970

F20.10

ICD-10 Finland

Raise schizophrenia continuously

0.0

8.9

257

ZXH09, ,

SPAT

1.5

8.9

267

1798

A10AA01, ,

ATC

0.5

8.9

1808

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.5

8.9

247

1637

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

8.9

1127

13501

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.8

448

3313

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

0.4

8.8

1242

-1, ,

NOMESCO Finland

0.9

8.8

3800

41560

SPAT1216

SPAT

Assessment of functional ability

0.8

8.8

1298

15341

N05AB03

ATC

perphenazine; systemic, rectal

0.6

8.8

174

2773

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.6

8.8

151

2487

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.3

8.8

802

A10BK01

ATC

dapagliflozin; oral

0.8

8.7

632

8057

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

8.7

1455

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.7

8.7

402

5456

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1.5

8.7

230

1507

R03DC03

ATC

montelukast; oral

1.2

8.7

2184

19218

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

8.7

2035

17814

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.5

8.6

244

1623

WX402

NOMESCO Finland

General anaesthesia

0.9

8.6

2526

28298

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.6

8.6

141

2351

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

8.6

826

6656

L50.0

ICD-10 Finland

Allergic urticaria

1.4

8.6

305

2122

S97

ICPC

Chronic ulcer skin

0.7

8.6

418

5627

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.6

839

TNG10

NOMESCO Finland

Puncture of knee

1.7

8.6

139

807

L20

ICPC

Joint symptom/complaint NOS

1.3

8.6

474

3553

R03AC03

ATC

terbutaline; inhalant

1.2

8.6

1714

14825

C09CA06

ATC

candesartan; oral

1.1

8.5

3313

30013

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

8.5

2112

18570

L60.9

ICD-10 Finland

Nail disorder, unspecified

1.6

8.5

203

1301

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.4

8.5

321

2261

F20

ICD-10 Finland

Schizophrenia

0.2

8.5

386

A12AA04

ATC

calcium carbonate; oral

0.4

8.4

979

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.4

8.4

337

2396

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

1.9

8.4

486

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

0.7

8.4

245

3600

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.5

8.4

270

1843

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.1

8.4

2392

21235

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

8.4

2206

19476

N05AX12

ATC

aripiprazole; systemic

0.7

8.4

216

3250

L50

ICD-10 Finland

Urticaria

1.6

8.4

202

1298

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.6

8.4

191

2947

R06AE09

ATC

levocetirizine; oral

1.2

8.3

1822

15867

A67.1

ICD-10 Finland

Intermediate lesions of pinta

+∞

8.3

A11CC03

ATC

alfacalcidol; systemic

0.5

8.3

1668

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

0.6

8.3

196

3003

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

8.3

725

5779

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.4

8.3

342

2446

NA3BG, ,

SPAT

1.3

8.2

500

3800

HAMTE, ,

NOMESCO Finland

0.2

8.2

534

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.3

8.2

581

4510

H3601, E113,

ICD-10 Finland

0.3

8.2

804

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

0.4

8.2

922

DM1QA, ,

SPAT

1.3

8.2

489

3709

N06DX01

ATC

memantine; oral

0.7

8.2

353

4839

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.7

8.2

142

841

EB1CA, ,

SPAT

1.9

8.2

103

555

M54.2

ICD-10 Finland

Cervicalgia

1.2

8.2

1008

8346

WX290, ,

SPAT

1.4

8.2

388

2842

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.5

8.2

1366

S80.0

ICD-10 Finland

Contusion of knee

1.2

8.1

951

7831

SPAT1059

SPAT

Spirometry at the office

0.7

8.1

318

4429

C07AB07

ATC

bisoprolol; oral

0.9

8.1

5833

62157

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.2

8.1

906

7425

PE1AT

NOMESCO Finland

Femoral artery PTA

0.3

8.1

707

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

8.1

1900

16634

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

0.4

8.1

1129

RF210, ,

NOMESCO Finland

0.6

8.1

128

2149

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.7

8.1

238

3485

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

8.1

503

6533

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.2

8.1

1177

9906

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

8.0

1277

C08CA01

ATC

amlodipine; oral

0.9

8.0

4443

47973

T89

ICPC

Diabetes insulin dependent

0.7

8.0

223

3302

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

8.0

4605

42627

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

0.5

8.0

1303

K80

ICPC

Cardiac arrhythmia NOS

1.2

8.0

1079

9013

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

8.0

831

6759

C07AB02

ATC

metoprolol; systemic

0.9

8.0

1726

19765

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

8.0

1177

9915

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

1.8

8.0

105

574

R05

ICPC

Cough

1.1

8.0

3509

32011

SPAT1104

SPAT

Monitoring of emergency patient

0.8

8.0

438

5788

AN2

Balloon angioplasty, including several vessels

0.6

8.0

102

1812

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.6

7.9

163

1009

EB4VA, ,

NOMESCO Finland

1.1

7.9

2348

20898

L03

ICD-10 Finland

Cellulitis

1.7

7.9

124

714

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

7.9

835

6803

WX730

NOMESCO Finland

Conventional respirator

0.4

7.9

1049

DFF59

NOMESCO Finland

Other assessment of balance

1.8

7.9

116

656

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

7.9

449

3383

DHB50

NOMESCO Finland

Turbinoplasty

1.4

7.9

284

1984

J01DC02

ATC

cefuroxime; systemic

1.3

7.9

625

4926

C01DA14

ATC

isosorbide mononitrate; oral

0.8

7.9

1028

12283

-1, ,

ICPC

0.7

7.9

207

3098

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.6

7.8

120

2032

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.2

7.8

947

7827

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.7

7.8

200

3011

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.2

7.8

858

7021

KE1BG

NOMESCO Finland

MRI of prostate

1.9

7.8

521

WX872

NOMESCO Finland

Intensive care

0.7

7.8

314

4349

L89

ICD-10 Finland

Decubitus ulcer and pressure area

0.5

7.8

1167

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

7.8

1554

NHQ40

NOMESCO Finland

Amputation of toe

0.4

7.7

940

R95

ICPC

Chron obstructive pulmonary disease

0.6

7.7

141

2285

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.6

7.7

128

2123

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.4

7.7

351

2555

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

1.6

7.7

172

1087

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

7.7

1352

11570

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.2

7.7

869

7134

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

7.7

664

5290

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

0.2

7.7

401

B35

ICD-10 Finland

Dermatophytosis

1.9

7.7

503

R1100, ,

SPAT

0.4

7.7

1007

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.7

7.6

118

677

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.3

7.6

516

3983

WX320

NOMESCO Finland

Spinalanesthesy

1.1

7.6

3246

29546

U09

ICD-10 Finland

Post COVID-19 condition

1.8

7.6

104

576

OAB48, ,

SPAT

1.1

7.6

2059

18215

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.3

7.6

635

5039

N05AH04

ATC

quetiapine; oral

0.9

7.6

1713

19553

N02AA01

ATC

morphine; systemic, rectal

0.5

7.6

1100

UJH02

NOMESCO Finland

Anoscopy

1.3

7.6

465

3544

R19.4

ICD-10 Finland

Change in bowel habit

1.4

7.5

343

2496

I49.1

ICD-10 Finland

Atrial premature depolarization

1.3

7.5

437

3302

F51.0

ICD-10 Finland

Nonorganic insomnia

1.1

7.5

2203

19589

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

0.7

7.5

250

3579

C01AA05

ATC

digoxin; systemic

0.7

7.5

364

4899

B01AA03

ATC

warfarin; systemic

0.9

7.5

1424

16477

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.3

7.5

460

3503

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.2

7.5

1043

8737

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

7.5

265

3754

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.5

7.5

214

1428

WVA20, ,

SPAT

0.7

7.5

215

3164

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

7.5

143

2294

D82

ICPC

Teeth/gum disease

1.1

7.5

5354

50064

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.6

7.5

113

1919

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

7.5

438

3315

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.5

969

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.5

7.5

255

1764

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

7.5

11260

108912

SPAT1281

SPAT

Other administrative function

0.8

7.5

579

7313

S72.0

ICD-10 Finland

Fracture of neck of femur

0.6

7.5

148

2352

WW500

NOMESCO Finland

Blood transfusion

0.7

7.5

227

3302

N05BA02

ATC

chlordiazepoxide; systemic

0.6

7.4

1662

K40

ICD-10 Finland

Inguinal hernia

1.5

7.4

224

1512

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.2

7.4

829

6795

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.6

7.4

151

933

ND1AA, ,

SPAT

1.4

7.4

334

2428

ND2AA, ,

SPAT

1.3

7.4

659

5269

D07AC01

ATC

betamethasone; topical

1.1

7.4

5083

47439

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.6

7.4

172

2638

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

0.2

7.4

390

U01

ICPC

Dysuria/painful urination

1.2

7.4

977

8149

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.5

7.4

222

1499

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

7.4

620

4924

J01MA02

ATC

ciprofloxacin; systemic

1.1

7.4

5220

48788

N05AF05

ATC

zuclopenthixol; systemic

0.3

7.3

621

M20.2

ICD-10 Finland

Hallux rigidus

1.4

7.3

363

2681

ZXC60

NOMESCO Finland

Application of heat

1.6

7.3

172

1102

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

0.3

7.3

572

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

0.6

7.3

107

1829

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

1.9

7.3

476

H57.1

ICD-10 Finland

Ocular pain

1.3

7.3

459

3512

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

0.2

7.3

489

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.4

7.2

342

2507

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

0.7

7.2

179

2709

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

7.2

337

2465

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

7.2

662

5313

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

0.4

7.2

825

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.2

761

9282

R49.03

ICD-10 Finland

Atrophic dysphonia

1.7

7.2

126

750

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.2

1018

8547

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

0.5

7.2

1292

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.3

7.2

411

3103

L29

ICD-10 Finland

Pruritus

1.6

7.2

170

1091

C07FB02

ATC

metoprolol and felodipine; systemic

0.6

7.1

118

1957

H40.1

ICD-10 Finland

Primary open-angle glaucoma

2.5

7.1

162

160

Kela drug reimbursment

exenatide

0.5

7.1

1461

NH1BG, ,

SPAT

1.5

7.1

191

1259

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

7.1

345

NB2AT, ,

SPAT

1.8

7.1

537

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

0.8

7.1

1103

12977

177

Kela drug reimbursment

Insulin glargine 300 U / ml

0.5

7.1

1381

B35.4

ICD-10 Finland

Tinea corporis

1.6

7.1

157

991

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

7.1

563

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

0.2

7.1

324

H81.3

ICD-10 Finland

Other peripheral vertigo

1.4

7.1

316

2294

E03

ICD-10 Finland

Other hypothyroidism

1.2

7.1

733

5962

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.5

7.1

1418

SFA20

NOMESCO Finland

Two-surface restoration

1.1

7.1

8898

85275

127

Kela drug reimbursment

Transplant complication

0.5

7.0

1137

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.3

7.0

431

3285

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

0.2

7.0

363

N07BA03

ATC

varenicline; oral

0.7

7.0

335

4514

TUPAE, ,

NOMESCO Finland

3.6

7.0

R01AD59

ATC

mometasone, combinations; nasal

1.2

7.0

785

6440

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.4

7.0

360

2675

UJD10, ,

SPAT

1.4

7.0

304

2199

R4120

NOMESCO Finland

Occupational therapy

1.2

7.0

758

6199

XQ800

NOMESCO Finland

Prick test

1.2

7.0

870

7217

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.2

7.0

817

6735

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

0.8

7.0

834

10045

XF610

NOMESCO Finland

Measurement of pulsvariation

3.3

6.9

Z04

ICD-10 Finland

Examination and observation for other reasons

1.5

6.9

173

1123

N05CD07

ATC

temazepam; oral

0.8

6.9

869

10423

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

0.4

6.9

811

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

6.9

1316

11336

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

6.9

921

7688

E0000UV, ,

ATC

1.1

6.9

5939

55966

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.2

6.9

1041

8791

SPD00

NOMESCO Finland

Mucosa borne complete denture

0.3

6.9

691

R01AD05

ATC

budesonide; nasal

1.2

6.9

869

7217

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.6

6.9

153

968

H25

ICD-10 Finland

Senile cataract

1.7

6.9

116

684

F16

ICPC

Eyelid symptom/complaint

1.3

6.9

622

4985

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

0.3

6.9

535

R56.8

ICD-10 Finland

Other and unspecified convulsions

0.7

6.8

306

4165

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

1.7

6.8

108

625

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

6.8

661

8139

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.5

6.8

182

1199

S15

ICPC

Foreign body in skin

1.2

6.8

777

6385

E86

ICD-10 Finland

Volume depletion

0.6

6.8

1569

L02

ICPC

Back symptom/complaint

1.2

6.8

1313

11321

WYA20

NOMESCO Finland

Home visit

0.5

6.8

1015

XX1XN

NOMESCO Finland

Other isotope examination

0.3

6.8

565

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.8

1704

14986

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.8

1131

9632

EBA00, ,

SPAT

1.4

6.8

289

2082

TK810

NOMESCO Finland

Hemofiltration

0.2

6.8

373

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

6.8

641

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.7

6.8

164

2493

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.8

1320

11392

C10AA07

ATC

rosuvastatin; oral

1.1

6.8

4817

44990

WZC30

NOMESCO Finland

Teaching

0.9

6.8

1731

19590

KAY20, ,

NOMESCO Finland

1.6

6.8

143

894

RTGOM, ,

NOMESCO Finland

3.0

6.7

XX2RW, ,

NOMESCO Finland

0.5

6.7

1092

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.1

6.7

2230

19985

K05.1

ICD-10 Finland

Chronic gingivitis

1.2

6.7

810

6696

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

6.7

126

2024

H3603, E103,

ICD-10 Finland

0.3

6.7

606

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

0.5

6.7

1276

H3603, E113,

ICD-10 Finland

0.2

6.7

462

XA402

NOMESCO Finland

ENMG

1.4

6.7

275

1971

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.3

6.7

432

3319

PD3AT

NOMESCO Finland

Pelvic artery PTA

0.2

6.7

333

J33.8

ICD-10 Finland

Other polyp of sinus

1.5

6.7

222

1531

T82

ICPC

Obesity

0.7

6.7

304

4124

J02

ICD-10 Finland

Acute pharyngitis

1.3

6.7

379

2860

M19.8

ICD-10 Finland

Other specified arthrosis

1.3

6.7

476

3707

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.6

696

5670

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.5

6.6

211

1442

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.6

1528

13358

M25.9

ICD-10 Finland

Joint disorder, unspecified

1.7

6.6

116

691

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.4

6.6

245

1724

NH1AA, ,

SPAT

1.3

6.6

366

2751

E87.5

ICD-10 Finland

Hyperkalaemia

0.5

6.6

1151

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

6.6

8292

79368

G50.1

ICD-10 Finland

Atypical facial pain

1.5

6.6

201

1363

H00.1

ICD-10 Finland

Chalazion

1.3

6.6

445

3440

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.4

6.6

734

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

1.6

6.6

150

955

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

6.6

1629

14317

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.3

6.6

440

3397

V03AE01

ATC

polystyrene sulfonate; oral

0.4

6.6

748

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.3

6.6

372

2806

Z50.0

ICD-10 Finland

Cardiac rehabilitation

0.3

6.6

583

J01FA06

ATC

roxithromycin; oral

1.1

6.5

5403

50792

R51.81

ICD-10 Finland

Facial pain NOS

1.4

6.5

268

1920

G03DC05

ATC

[U] tibolone

1.3

6.5

492

3857

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

0.6

6.5

130

2060

Z10.0

ICD-10 Finland

Occupational health examination

1.2

6.5

1065

9058

A03FA01

ATC

metoclopramide; systemic, rectal

0.9

6.5

2449

27048

C10AC01

ATC

colestyramine; oral

1.4

6.5

310

2278

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.5

3302

35876

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

0.2

6.5

469

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.5

815

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

6.5

948

7985

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.6

6.5

1506

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.4

6.5

230

1607

D11

ICPC

Diarrhoea

1.2

6.5

1493

13057

D06BX02

ATC

ingenol mebutate; topical

1.7

6.4

115

689

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.3

6.4

545

4335

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.1

6.4

2251

20239

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.2

6.4

1137

9736

C02EA02, ,

ATC

0.7

6.4

169

2524

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

0.6

6.4

1553

NB1BG, ,

SPAT

1.4

6.4

272

1961

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

0.6

6.4

131

2062

DM1AI, ,

SPAT

1.8

6.4

483

XQ855, ,

SPAT

0.4

6.4

893

G01AA10

ATC

clindamycin; vaginal

1.1

6.4

1817

16126

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.6

6.4

133

830

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

6.3

3650

33728

R41.3

ICD-10 Finland

Other amnesia

1.4

6.3

292

2134

D06

ICPC

Abdominal pain localized other

1.2

6.3

1138

9759

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.3

6.3

568

4550

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.7

6.3

148

2262

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

1.5

6.3

159

1036

SPAT1053

SPAT

Memory test

0.8

6.3

1056

12334

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

0.5

6.3

1313

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.3

6.3

563

4512

E66.9

ICD-10 Finland

Obesity, unspecified

0.7

6.2

222

3134

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

6.2

1551

13634

1048X

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[INFECTIO SPIROCHAETALES ALIA DEFINITA]

+∞

6.2

A67.9

ICD-10 Finland

Pinta, unspecified

+∞

6.2

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.8

6.2

461

5851

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.3

6.2

447

3484

XQ899

NOMESCO Finland

Other assessment of skin

2.1

6.2

263

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

1.5

6.2

177

1184

H01

ICPC

Ear pain/earache

1.2

6.2

1491

13073

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

0.4

6.2

641

ITSEH, ,

NOMESCO Finland

0.2

6.2

297

H53

ICD-10 Finland

Visual disturbances

1.7

6.2

104

614

NB1DG, ,

SPAT

1.6

6.2

130

813

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.2

5005

46988

N64.4

ICD-10 Finland

Mastodynia

1.3

6.2

384

2937

WX702

NOMESCO Finland

Supraglottic ventilation device

0.8

6.2

442

5630

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

0.2

6.2

276

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

0.4

6.2

711

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.3

6.1

508

4031

R52.0

ICD-10 Finland

Acute pain

1.3

6.1

357

2705

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

6.1

3935

36548

P70

ICPC

Dementia

0.5

6.1

1239

C50

ICD-10 Finland

Malignant neoplasm of breast

1.4

6.1

285

2088

I25.2

ICD-10 Finland

Old myocardial infarction

0.7

6.1

315

4192

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

0.3

6.1

530

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.6

6.1

1341

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.3

6.1

375

2864

I84

ICD-10 Finland

Hemorrhoids

1.4

6.1

279

2038

OAB72

NOMESCO Finland

Weight control and weight loss guidance

0.4

6.1

620

EBA30

NOMESCO Finland

Extraction of root of tooth

0.8

6.1

419

5363

L01CB01

ATC

etoposide; systemic

0.2

6.1

316

Z51.6

ICD-10 Finland

Desensitization to allergens

1.7

6.1

112

678

N07BB01

ATC

disulfiram; oral

0.7

6.1

260

3557

SPAT1251

SPAT

Organisation of medication

0.7

6.1

156

2337

A10AD01

ATC

insulin (human); parenteral

0.5

6.1

888

E66.8

ICD-10 Finland

Other obesity

0.8

6.0

433

5515

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

0.4

6.0

761

K07.60

ICD-10 Finland

Snapping jaw

1.2

6.0

588

4758

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.6

6.0

1283

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3989

9939

4.91

307.65

1.7

1.2

62.66

43.95

au/ml

8.25

787

417

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4441

10666

5.25

307.65

3.2

2.3

29.07

18.80

au/ml

14.01

973

1002

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

414

475

8.90

307.65

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

421

551

7.81

301.39

1.1

986.20

307.72

ng/l

1.16

126

140

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

408

637

6.54

248.52

1.1

0.11

0.99

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3135

18900

1.80

174.09

5.1

5.0

32.98

32.35

2.23

1828

12896

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

551

1634

3.45

152.12

1.1

31.99

4.70

au/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

364

6.25

132.26

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

485

1456

3.40

131.26

1.1

—

(40761536) Microorganisms panel - Urine sediment

477

13049

0.35

119.75

4.2

4.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

869

4112

2.17

95.01

1.2

1.4

567.04

530.23

mg/l

1.30

845

3927

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

592

13144

0.43

90.17

2.8

3.9

1.23

mmol/l

1.31

528

11365

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

820

16120

0.48

89.52

2.5

3.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

15760

147995

1.71

87.70

13.7

15.6

82.74

81.98

ml/min/173m2

6.08

14393

137139

(3019225) pH of Specimen

2277

15016

1.59

84.29

3.6

4.3

7.37

7.36

0.63

1392

10896

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

763

3634

2.15

81.88

1.2

1.3

3.52

3.76

mmol/l

10.97

718

3447

(3000963) Hemoglobin [Mass/volume] in Blood

17119

166082

3.39

79.22

22.2

24.8

136.41

135.29

g/l

25.93

16939

164627

(3007461) Platelets [#/volume] in Blood

17111

165991

3.31

78.58

22.1

24.6

248.68

254.25

e9/l

28.48

16741

162891

(3026361) Erythrocytes [#/volume] in Blood

17114

166052

3.33

78.26

22.0

24.6

4.52

4.49

e12/l

10.07

16652

162441

(3035941) MCH [Entitic mass]

17112

166033

3.31

78.03

22.0

24.5

30.39

30.31

8.82

16930

164553

(3024731) MCV [Entitic mean volume] in Red Blood Cells

17112

166038

3.31

77.93

22.0

24.5

91.18

91.07

2.94

16928

164560

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

17112

166046

3.30

77.76

22.4

25.1

41.00

40.89

0.14

16926

164508

(3010813) Leukocytes [#/volume] in Blood

17112

166072

3.29

77.23

22.1

24.6

6.37

6.69

e9/l

52.01

16690

162415

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

160

7.10

75.47

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16747

161463

2.08

68.03

12.3

12.6

25.67

26.36

u/l

6.00

16218

157374

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

313

1129

2.80

61.74

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

335

1259

2.69

61.07

1.2

53.46

40.39

mg/l

2.74

319

1049

(3023410) Appearance of Cerebral spinal fluid

395

1613

2.48

60.73

1.3

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

897

15331

0.56

60.39

4.3

4.5

0.90

0.95

0.20

298

4592

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16139

154503

1.64

58.43

6.0

5.9

2.79

2.74

mmol/l

11.71

14933

144899

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

324

1227

2.67

58.19

1.1

318.02

257.28

mg/l

3.91

310

1076

(3021440) Promyelocytes/Leukocytes in Blood

866

14679

0.57

56.30

4.4

4.6

0.10

0.12

0.20

269

3957

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15892

151782

1.56

55.72

5.3

5.1

1.53

1.48

mmol/l

47.69

14696

142079

(3002179) Metamyelocytes/Leukocytes in Blood

868

14631

0.57

55.20

4.2

4.4

0.69

0.72

0.13

315

4378

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4880

39595

1.32

55.18

2.2

2.4

—

(3025159) Blasts/Leukocytes in Blood

885

14836

0.57

55.14

4.6

4.8

0.05

0.36

4.58

258

3783

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16751

162289

1.94

54.97

18.3

20.8

74.07

75.79

umol/l

19.47

16515

160698

(3010421) pH of Blood

164

5244

0.31

54.81

3.0

3.6

7.41

0.26

164

5181

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15954

152607

1.57

54.40

5.2

4.76

4.68

mmol/l

20.30

14824

143645

(3047181) Lactate [Moles/volume] in Blood

146

4912

0.29

53.68

3.2

5.9

1.22

1.30

mmol/l

0.71

135

4342

(3029937) Albumin [Presence] in Urine by Test strip

3797

47404

0.75

52.82

3.8

4.2

0.00

estimate

4.59

863

16690

(3041096) Erythrocytes [Presence] in Urine by Automated

3706

46213

0.75

50.58

2.7

3.4

0.90

0.24

estimate

0.71

711

14365

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

323

7296

0.43

50.22

3.1

5.1

1.48

1.63

2.03

311

6909

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3602

28326

1.34

49.56

3.0

0.83

1.23

e6/l

2.92

1831

14993

(3007930) Methemoglobin/Hemoglobin.total in Blood

279

6647

0.41

49.53

3.4

5.4

0.84

0.88

0.60

271

6279

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

312

1258

2.51

49.34

1.2

1.3

1.91

2.13

mmol/l

3.59

284

1176

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2528

33268

0.72

48.86

1.5

1.7

28038719.15

32896023.03

pmol/l

0.19

2090

27870

(3033658) Prothrombin time (PT) actual/Normal

5006

41360

1.30

48.04

3.6

4.2

92.42

91.11

3.64

4901

40433

(3011397) Hemoglobin [Presence] in Urine by Test strip

4750

39129

1.29

46.23

3.5

3.8

0.29

0.31

—

363

(3008152) Bicarbonate [Moles/volume] in Arterial blood

541

9938

0.53

46.11

6.5

7.2

24.73

24.58

mmol/l

0.59

531

9518

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3238

25302

1.34

46.01

3.5

3.2

0.72

0.76

ug/l

1.48

2077

16523

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

875

2.76

45.93

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12710

117922

1.29

45.62

4.7

4.5

10.09

11.95

mm/h

59.42

11837

110906

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15199

144790

1.40

44.79

4.4

4.3

1.22

1.30

mmol/l

37.74

13872

134298

(3035320) C reactive protein [Mass/volume] in Body fluid

296

1235

2.42

43.52

3.0

2.7

25.06

27.73

mg/l

0.63

212

890

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15209

145216

1.38

41.38

5.9

6.4

37.86

39.15

mmol/mol

101.09

13999

136744

(3027315) Oxygen [Partial pressure] in Blood

3380

0.26

40.92

3.3

3.9

8.84

8.70

kpa

0.40

3308

(3013290) Carbon dioxide [Partial pressure] in Blood

3357

0.26

40.44

3.3

3.9

5.02

5.00

kpa

0.09

3286

(3018572) Chloride [Moles/volume] in Blood

3387

0.26

40.40

3.8

7.0

104.94

105.11

mmol/l

0.19

3047

(3012501) Base excess in Blood by calculation

3355

0.26

40.40

3.3

3.9

1.92

2.47

mmol/l

2.14

2289

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15880

152868

1.46

40.38

14.1

16.1

22.43

23.65

mg/l

4.42

12626

126014

(3039000) Anion gap in Blood by calculation

3386

0.26

40.38

3.8

7.0

11.31

11.20

mmol/l

0.14

3045

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2369

17975

1.37

40.17

5.1

6.7

—

(3014051) Protein [Presence] in Urine by Test strip

5431

46102

1.26

40.07

2.8

2.9

0.00

0.07

8.46

991

(40768443) Skin Pathology biopsy report

1140

7544

1.55

40.07

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

386

1871

2.09

39.53

1.8

2.1

20.97

25.57

mg/l

0.99

733

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3620

29266

1.30

39.52

1.4

1.3

11.47

11.78

u/ml

0.09

1198

11582

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

641

3685

1.77

39.21

1.3

1.5

414.58

2582.36

e6/l

1.37

466

2903

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

211

790

2.69

38.90

1.2

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7920

70483

1.23

36.89

2.2

2.1

100.77

97.17

pmol/l

7.95

3814

37309

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2266

17297

1.36

36.71

2.0

3.37

3.47

ratio

3.42

1766

13330

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3851

31671

1.28

36.28

1.4

1.3

33.91

33.20

iu/ml

0.08

1074

9731

(3006462) Nitrate [Presence] in Urine

182

657

2.79

36.03

4.1

3.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

621

3635

1.73

35.65

1.2

1.4

36.24

38.86

e6/l

0.09

429

2675

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

712

4348

1.66

34.94

1.2

3.90

3.81

0.10

603

(1616796) Gas panel - Central venous blood

125

3636

0.34

34.57

3.1

3.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5620

64437

0.81

34.39

3.3

3.9

2.12

0.44

estimate

0.78

716

14695

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3186

25778

1.29

33.83

3.0

3.1

2.37

2.86

e6/l

1.71

1406

12398

(3037522) Nuclear Ab [Titer] in Serum

2994

24070

1.29

33.34

1.4

479.75

524.69

titre

0.73

641

5168

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15044

144206

1.33

33.20

5.7

5.6

1.89

mu/l

0.24

13729

134546

(4211845) Urine protein measurement

186

725

2.58

31.73

4.0

3.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

189

4.25

30.81

1.2

1.3

79.00

51.47

6.20

(3007164) IgA [Mass/volume] in Serum or Plasma

3984

33445

1.25

30.63

1.5

2.31

2.40

g/l

2.06

2164

20802

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

764

4915

1.58

30.31

1.3

5.43

7.77

u/ml

0.51

728

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

764

4920

1.58

30.18

1.3

2.16

5.85

u/ml

2.01

481

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

194

793

2.46

29.98

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1695

12777

1.36

29.36

1.7

3.49

mmol/l

0.00

1186

8768

(3003327) Ova and parasites identified in Stool by Light microscopy

894

6003

1.52

29.23

1.8

1.7

—

(3018010) Neutrophils/Leukocytes in Blood

8443

76624

1.20

29.19

6.7

55.66

57.08

25.79

7907

73402

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15350

148003

1.32

29.05

5.3

5.2

5.75

5.92

mmol/l

82.77

13998

137252

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.58

28.70

1.1

1.2

7.00

26.05

1.85

(3004616) Nuclear Ab [Presence] in Serum

397

2178

1.84

28.43

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

800

5294

1.54

27.99

1.3

38.72

40.53

u/ml

0.05

287

(36660697) Celiac disease serology panel - Serum

1766

13515

1.34

27.61

1.2

—

(3035715) Granulocytes [#/volume] in Blood

112

3078

0.36

27.54

3.7

3.4

3.74

4.05

e9/l

1.23

112

3073

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

311

1608

1.95

26.74

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1020

7192

1.44

26.04

1.7

1.8

8.41

7.16

iu/ml

0.50

205

1736

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

401

2.93

25.63

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

646

4161

1.57

25.50

1.2

1.3

1.15

4.65

u/ml

3.11

274

(3037467) Urinalysis macro (dipstick) panel - Urine

11481

107779

1.19

25.10

4.6

1.68

2.39

0.90

163

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

664

4334

1.55

24.73

1.3

14.26

14.23

u/ml

—

(3026782) Osmolality of Urine

2503

30473

0.79

24.66

2.5

3.0

548.10

526.61

mosm/kgh2o

5.19

2075

26784

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

180

779

2.32

24.59

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

396

2.89

24.40

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

16031

156060

1.36

24.33

15.9

18.9

3.95

3.96

mmol/l

7.43

15642

153047

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

328

1782

1.86

24.30

1.2

30.94

45.90

u/ml

0.34

101

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1993

15781

1.30

24.24

2.3

2.6

37.21

49.25

u/l

1.36

1691

13396

(3019550) Sodium [Moles/volume] in Serum or Plasma

15998

155742

1.35

23.82

15.7

18.7

139.92

139.71

mmol/l

25.36

15648

152975

(3013650) Neutrophils [#/volume] in Blood by Automated count

9968

92656

1.18

23.67

9.1

10.2

3.74

4.09

e9/l

43.40

8420

80596

(3044640) Blood type and Crossmatch panel - Blood

5862

52159

1.19

23.52

2.2

2.5

—

(3048689) Calprotectin [Mass/mass] in Stool

2658

21899

1.25

23.29

2.3

2.4

110.03

133.04

ug/g

3.15

2032

17469

(3006315) Basophils [#/volume] in Blood

9020

83223

1.17

23.26

6.7

6.6

0.04

e9/l

1.73

7555

71740

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

111

391

2.85

23.18

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

8304

76131

1.17

23.09

6.8

2.92

2.85

2.28

7697

71576

(3013115) Eosinophils [#/volume] in Blood

9265

85702

1.17

23.05

6.8

0.19

e9/l

3.01

7929

75075

(3019069) Monocytes/Leukocytes in Blood

8323

76329

1.17

23.03

6.9

8.83

8.79

0.66

7723

71829

(3001604) Monocytes [#/volume] in Blood

8991

83003

1.17

22.81

6.7

6.6

0.55

0.58

e9/l

38.84

7538

71565

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8148

74637

1.17

22.76

2.4

2.5

79.25

1278.91

nmol/l

0.50

7185

68254

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11427

107590

1.18

22.71

3.3

3.4

40.67

47.81

u/l

19.50

10685

101478

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

458

2802

1.65

22.39

1.1

17.89

14.64

au/ml

0.30

107

678

(3020682) Albumin/Creatinine [Ratio] in Urine

4763

53924

0.84

22.23

3.7

4.2

6.09

8.42

mg/mmol

1.63

2650

33065

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

405

2409

1.70

22.04

1.2

2.48

12.84

u/ml

3.21

103

(3027273) Bicarbonate [Moles/volume] in Venous blood

438

7013

0.61

22.03

2.6

3.6

25.30

25.28

mmol/l

0.05

431

6790

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

259

1346

1.94

22.02

1.2

—

(3022096) Basophils/Leukocytes in Blood

8285

76135

1.17

21.86

6.9

0.73

0.69

8.33

7676

71539

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

264

1386

1.92

21.78

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

9149

84765

1.17

21.65

6.7

6.6

1.93

e9/l

0.02

7854

74812

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1384

1.91

21.23

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

264

1406

1.89

20.88

1.2

—

(3000012) Reticulocyte production index

2251

0.35

20.79

2.2

2.1

0.94

0.92

0.12

1506

(3022806) Fractional oxyhemoglobin in Capillary blood

1886

0.29

20.78

1.8

91.22

89.92

0.94

1858

(3002030) Lymphocytes/Leukocytes in Blood

8459

78079

1.16

20.51

6.7

6.8

29.52

28.08

29.94

7957

74191

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

267

1436

1.87

20.50

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

800

5637

1.44

20.48

2.6

2.5

0.72

0.80

g/l

0.27

696

4868

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

679

4652

1.48

20.13

1.5

23.97

16.25

iu/ml

0.44

103

(3018333) Ribosomal P Ab [Presence] in Serum

247

1303

1.91

20.13

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1334

1.89

20.00

1.2

—

(3022145) Colonoscopy Study observation

2347

19400

1.24

19.69

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

385

2334

1.66

19.55

1.1

3.63

2.51

0.44

383

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

366

2.74

19.52

1.1

—

(3003396) Base excess in Arterial blood by calculation

1483

18709

0.77

19.11

6.9

8.0

0.50

0.93

mmol/l

5.38

1306

15577

(3027801) Oxygen [Partial pressure] in Arterial blood

1498

18859

0.77

18.98

7.0

8.1

13.49

12.56

kpa

7.39

1460

18198

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

271

4716

0.57

18.96

1.4

1.7

—

(3022621) pH of Urine by Test strip

1610

12785

1.29

18.93

2.5

2.6

6.00

6.06

1.89

892

8541

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

203

3.36

18.90

1.1

1.2

—

(3019977) pH of Arterial blood

1500

18866

0.78

18.85

7.0

8.1

7.43

7.42

3.00

601

10263

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1500

18866

0.78

18.85

7.0

8.1

5.09

5.10

kpa

0.10

1460

18212

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2127

0.37

18.71

2.3

2.1

33.27

32.60

0.95

2111

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4798

42596

1.17

18.69

6.1

5.5

2.29

3.03

ug/l

3.36

4299

38791

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1227

15773

0.76

18.21

7.8

8.9

122.71

121.09

g/l

2.37

1218

15412

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

199

1011

1.98

18.17

1.1

0.85

1.18

—

(3016502) Oxygen saturation in Arterial blood

1323

16793

0.77

17.81

7.4

8.4

95.87

95.69

0.42

1306

16232

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

267

1503

1.79

17.75

1.2

79.30

79.96

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1547

12323

1.28

17.71

2.3

13.72

13.00

nmol/l

2.89

1383

11163

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

906

12113

0.73

17.67

2.2

2.9

135.79

174.83

ng/l

5.09

816

11077

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

291

1682

1.74

17.67

1.2

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13404

128799

1.18

17.48

18.7

20.6

332.49

332.22

g/l

3.31

13355

128185

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

619

4287

1.46

17.40

2.7

2.5

0.00

g/l

-0.00

575

4018

(3005988) Vibrio sp identified in Specimen by Organism specific culture

329

1979

1.68

17.27

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3882

34061

1.18

17.18

4.5

21.72

21.89

0.28

1853

16574

(3031040) Bacteria [#/volume] in Urine by Automated count

10890

103080

1.15

17.04

4.5

4.7

5102.92

1636.35

e6/l

0.68

1379

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4076

35935

1.18

16.99

1.7

1.8

1.02

1.18

mg/l

1.86

3032

27954

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

327

1977

1.67

16.85

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7428

68533

1.15

16.69

1.8

1.9

1.27

1.37

mmol/l

24.84

6249

57661

(1761482) Bacteria [#/volume] in Urine by Culture

187

3485

0.53

16.65

4.0

4.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

325

1970

1.66

16.59

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

781

5705

1.39

16.30

1.6

1.7

3.18

4.36

mg/l

3.12

562

4259

(40762887) Creatinine [Moles/volume] in Blood

108

4.08

16.27

1.3

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1792

21703

0.81

16.07

4.5

6.3

1.02

1.04

mmol/l

2.08

1632

20304

(3020779) Urea [Moles/volume] in Serum or Plasma

1137

14524

0.77

16.00

5.3

7.9

8.06

9.55

mmol/l

14.12

1085

13950

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

569

3946

1.46

15.91

1.2

1.3

43.52

44.85

u/ml

0.05

371

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

647

4597

1.42

15.87

2.7

2.4

0.00

g/l

1.12

576

4028

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

860

6417

1.36

15.73

1.6

12.73

17.24

u/ml

1.42

164

1490

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7838

72762

1.14

15.71

5.5

6.8

1.22

1.21

mmol/l

18.32

7118

67647

(3000034) Microalbumin [Mass/volume] in Urine

1397

0.29

15.68

3.1

3.0

72.07

49.76

mg/l

0.16

1004

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12708

121922

1.16

15.57

7.9

8.6

75.40

78.98

u/l

15.84

11961

116286

(3012516) Albumin [Mass/volume] in Urine

4789

53090

0.86

15.55

3.3

3.5

34.52

46.29

mg/l

1.95

2729

33258

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

188

3.20

15.50

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

696

9498

0.72

15.45

8.6

10.2

16.24

16.03

1.39

689

9169

(40758558) Short blood count panel - Blood

5442

49324

1.15

15.43

6.7

6.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

667

4793

1.41

15.35

2.7

2.4

0.01

0.03

g/l

0.64

602

4316

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1961

16310

1.23

15.28

2.2

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

830

6190

1.36

15.24

2.6

2.4

2.82

2.88

g/l

1.06

744

5656

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

605

4279

1.43

15.23

1.1

1.2

—

(3002256) Pathology report gross observation

2574

21996

1.20

15.19

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

229

3921

0.58

15.14

1.7

2.3

130.96

129.71

g/l

0.28

121

2990

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

187

3.16

14.97

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

333

2086

1.61

14.95

1.4

—

(3032080) INR in Blood by Coagulation assay

6722

72671

0.88

14.90

12.9

13.9

1.22

inr

0.01

5068

60510

(42529406) Shigella sp [Presence] in Stool by Culture

606

4324

1.42

14.54

1.1

1.2

—

(44806420) Estimation of glomerular filtration rate

1885

0.41

14.51

2.2

2.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

603

4313

1.41

14.28

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

335

2128

1.59

14.21

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

329

2084

1.59

14.13

1.4

—

(3023368) Bacteria identified in Blood by Culture

3850

43112

0.86

14.01

3.6

4.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1024

7973

1.30

13.95

1.7

—

(3021589) Normoblasts [#/volume] in Blood

6693

72170

0.88

13.86

9.2

11.8

0.00

e9/l

3.79

5038

59018

(3009508) Creatinine [Moles/volume] in Urine

5200

56888

0.88

13.35

3.2

3.5

7.65

7.50

mmol/l

1.58

4237

48404

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5060

55432

0.88

13.23

3.0

3.4

31.35

33.97

u/l

3.21

4767

52358

(3040151) Glucose [Moles/volume] in Capillary blood

1812

0.43

13.21

1.7

10.1

6.92

7.53

mmol/l

0.74

1527

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

261

1590

1.65

13.17

1.3

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4281

38491

1.15

13.15

1.3

1.72

1.69

u/ml

0.04

888

10612

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

6542

1.32

13.10

2.5

2.4

4.17

4.25

g/l

1.68

769

6012

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

163

868

1.89

13.10

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

161

854

1.89

13.09

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

6549

1.32

13.01

2.5

2.4

7.06

7.39

g/l

7.01

767

6012

(3019420) Tryptase [Mass/volume] in Serum or Plasma

173

942

1.84

12.97

1.5

6.05

8.16

ug/l

2.66

166

853

(3021960) Folate [Moles/volume] in Serum or Plasma

4997

45453

1.14

12.88

1.6

1.7

21.61

20.28

nmol/l

8.67

4017

38780

(3026493) Urate [Moles/volume] in Serum or Plasma

4724

42839

1.14

12.72

2.5

2.7

328.37

337.47

umol/l

9.43

4102

37988

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

849

6529

1.32

12.68

2.5

2.4

3.56

3.69

g/l

1.89

762

5997

(1002224) Polysomnography panel

1004

7901

1.29

12.61

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

445

6316

0.70

12.49

1.9

2.0

1.48

2.12

ug/l

1.02

397

5676

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

365

5369

0.67

12.43

1.5

1.8

—

32.21

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

142

737

1.93

12.36

1.1

5.63

7.52

u/ml

0.47

123

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1773

14910

1.21

12.26

2.1

2.0

—

(3045414) Leukocytes [Presence] in Urine

1881

15913

1.20

12.22

2.2

2.1

0.00

0.02

estimate

7.07

218

3327

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

412

2842

1.46

11.95

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

194

1123

1.74

11.89

1.1

25.70

19.69

u/ml

0.76

456

(1761868) Lipid panel - Serum or Plasma

5753

62226

0.89

11.88

2.7

3.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

325

2.41

11.87

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

416

2882

1.45

11.80

1.5

1.17

1.15

ratio

0.15

241

1748

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

220

3567

0.61

11.80

2.2

2.4

98.20

108.90

ug/min

0.15

124

2147

(3038026) Centromere Ab [Units/volume] in Serum

215

1287

1.68

11.67

1.3

1.2

35.81

54.03

u/ml

0.69

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

416

2890

1.45

11.64

1.5

1.16

1.22

ratio

0.73

244

1770

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

416

2890

1.45

11.64

1.5

0.98

0.95

ratio

0.73

241

1757

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

163

903

1.81

11.62

1.1

1.22

1.10

u/l

0.76

367

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

588

7832

0.74

11.17

2.9

4.1

50.87

48.21

1.94

581

7723

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

124

638

1.95

11.12

2.0

2.1

40.86

40.24

g/l

0.47

124

638

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1973

0.50

11.07

1.4

1.5

59.99

59.60

ug/l

0.03

1973

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

727

5598

1.31

10.80

2.5

2.4

9.98

10.10

g/l

0.34

631

5011

(3051387) C reactive protein [Mass/volume] in Capillary blood

195

3176

0.61

10.70

3.4

3.5

30.45

26.22

mg/l

0.50

2184

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1260

0.39

10.70

1.3

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12774

123557

1.13

10.67

4.5

4.6

14.61

14.75

pmol/l

8.93

11578

114329

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

167

2.88

10.49

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

554

4120

1.36

10.46

1.6

10502.52

13683.09

e6/l

1.47

391

2901

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

700

5392

1.31

10.38

1.1

0.60

0.62

ratio

0.34

721

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

151

2598

0.58

10.32

1.4

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

428

3060

1.41

10.28

1.6

1.5

66.86

60.25

ug/l

0.79

347

2525

(3033099) Centromere Ab [Titer] in Serum

420

2.12

10.15

1.1

—

(3012544) pH of Venous blood

1369

16296

0.83

10.08

3.0

4.2

7.38

1.38

644

9321

(3005719) IgG [Mass/volume] in Serum or Plasma

1547

13079

1.20

10.07

2.8

2.9

10.41

10.50

g/l

0.38

1452

12124

(36304419) Bacteria [Presence] in Urine

4687

42983

1.12

10.07

3.2

0.33

274.41

estimate

0.87

164

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1041

8456

1.25

10.06

1.1

16.98

7.73

u/ml

—

100

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

915

7324

1.26

10.05

2.0

42.13

39.61

u/l

3.24

807

6547

(3008898) HLA-B27 [Presence]

723

5633

1.30

9.87

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1349

16044

0.83

9.84

2.9

4.1

5.81

5.82

kpa

0.20

1322

15663

(46235355) HIV 1 and 2 tests - Meaningful Use set

3144

28172

1.14

9.74

1.9

—

(3000494) Fungus identified in Specimen by Culture

2316

20313

1.16

9.70

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

151

2553

0.59

9.68

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

365

5116

0.71

9.61

2.5

3.4

0.35

iu/ml

0.07

181

2819

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

114

2077

0.55

9.61

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2471

27911

0.87

9.59

2.8

3.6

0.83

0.82

mmol/l

10.27

2291

26363

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

200

1241

1.62

9.53

1.1

8.29

8.56

iu/ml

0.06

312

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1044

8538

1.24

9.49

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12516

128950

0.89

9.42

17.4

19.8

13.42

13.60

65.42

12394

127359

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

283

1904

1.49

9.42

1.5

1.8

10537.14

1384.44

titre

—

(3004775) Volume in Urine collected for unspecified duration

1178

0.41

9.20

2.7

2.3

641.74

665.29

0.20

827

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1131

9359

1.22

9.19

1.6

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

989

0.36

9.18

21.1

20.2

1300.94

2394.14

nmol/l

0.58

952

(3002032) Base excess in Venous blood by calculation

1320

15632

0.83

9.18

2.9

4.1

1.62

1.83

mmol/l

1.58

1198

13783

(3013139) Helicobacter pylori Ag [Presence] in Stool

1386

11703

1.20

9.14

1.3

—

(40762814) Titanium [Mass/volume] in Blood

233

2.45

9.14

2.7

2.5

2.97

3.78

ug/l

1.17

(4027681) Cerebrospinal fluid IgG ratio and IgG index

165

986

1.68

9.13

1.2

0.59

0.69

ratio

0.58

108

562

(3018095) Leukocytes [#/volume] in Urine

6390

59849

1.11

9.12

4.0

52.15

94.79

e6/l

11.13

4015

41989

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

365

2599

1.41

9.03

1.2

0.69

1.07

1.03

100

(3004119) Hemoglobin [Mass/volume] in Venous blood

790

9837

0.79

8.97

2.2

3.5

133.88

129.28

g/l

8.58

770

9559

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

165

993

1.67

8.90

1.1

4.59

7.69

nmol/l

0.56

188

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1563

18169

0.85

8.77

1.7

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

935

0.36

8.72

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

706

5580

1.28

8.65

2.7

2.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

975

0.38

8.64

1.4

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

163

2.70

8.63

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

255

1713

1.50

8.59

1.6

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4853

52300

0.90

8.57

2.5

2.7

62.38

64.85

u/l

0.39

4392

48554

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

158

2.73

8.56

1.1

—

(3044889) 12 lead EKG panel

10619

110141

0.91

8.51

3.7

4.0

0.18

3379.57

1.18

226

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

2.73

8.41

1.0

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

676

5337

1.28

8.37

1.8

1.7

1.18

1.20

g/l

0.53

640

5110

(3041354) Potassium [Moles/volume] in Venous blood

1626

0.53

8.28

1.9

2.3

4.03

mmol/l

0.04

1610

(3035285) Chloride [Moles/volume] in Venous blood

1625

0.53

8.26

1.9

2.3

106.03

105.47

mmol/l

0.55

1609

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8041

76424

1.10

8.18

3.1

3.2

109.27

124.58

ug/l

7.75

7453

71635

(3025018) Bordetella pertussis Ab [Titer] in Serum

184

1165

1.59

8.14

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

655

5182

1.27

7.99

1.8

0.23

0.24

g/l

1.03

615

4941

(3019150) Specific gravity of Urine by Refractometry

3436

37612

0.89

7.97

3.6

4.1

1.02

1.14

kg/l

1.09

2114

24935

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

520

0.19

7.93

1.1

3.5

11.92

10.44

kpa

—

520

(3003434) Protein [Mass/volume] in Pleural fluid

125

2101

0.59

7.92

1.4

1.5

33.32

33.61

g/l

0.10

113

1919

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1036

0.42

7.92

1.3

1.4

—

(4146454) Self-monitoring of blood glucose

247

1678

1.48

7.91

2.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

519

0.19

7.90

1.1

3.5

4.65

4.97

kpa

—

519

(4015189) Microbial culture of sputum

388

2.01

7.84

1.6

2.1

—

(3005033) Fetal Nuchal fold Thickness US

328

2353

1.40

7.84

1.5

1.28

1.25

0.44

236

1696

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

622

4904

1.28

7.81

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

601

4719

1.28

7.80

1.9

44.80

41.67

nmol/l

2.55

585

4595

(3047352) Trisomy 18 risk [Likelihood] in Fetus

333

2398

1.40

7.79

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1594

0.54

7.78

1.9

2.3

1.20

mmol/l

0.41

1578

(3043238) Trisomy 21 risk [Likelihood] in Fetus

340

2461

1.39

7.72

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

382

5122

0.74

7.69

2.9

3.6

1.29

1.52

mg/l

9.95

355

4692

(3023183) Ammonium ion [Moles/volume] in Plasma

247

3549

0.69

7.58

3.1

2.8

32.00

34.00

umol/l

0.71

221

3216

(3019832) Treponema pallidum Ab [Presence] in Serum

1572

13641

1.17

7.52

1.7

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

516

0.21

7.48

7.0

6.5

26.61

25.10

mmol/l

1.25

471

(3000850) Epithelial cells [#/volume] in Urine

3302

36111

0.89

7.47

2.6

2.8

4.72

5.76

e6/l

3.82

2929

32931

(37208534) Antinuclear antibody arbitrary concentration in serum

100

551

1.82

7.44

1.0

1.1

—

(3015736) pH of Urine

7215

68463

1.09

7.29

3.2

3.5

6.20

6.22

0.53

3498

38245

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

306

2200

1.40

7.26

1.1

3.83

3.59

eliau/ml

0.07

120

1041

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1244

0.50

7.25

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

870

0.40

7.23

1.6

2.1

7.65

8.10

mmol/l

0.36

870

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

197

2.39

7.22

1.1

—

(3042631) Mycobacterium sp identified in Specimen

130

2110

0.61

7.19

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

149

2340

0.63

7.15

4.8

6.5

10.77

11.82

mg/l

2.38

138

2170

(3004451) EKG impression Narrative

893

0.41

7.13

1.4

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

702

5681

1.25

7.10

3.1

4.0

24.93

24.86

mmol/l

0.30

651

5263

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

186

2783

0.66

7.10

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

226

3250

0.69

7.01

1.4

—

(3023419) Bacteria identified in Sputum by Culture

136

2166

0.62

6.96

2.5

2.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

230

3282

0.70

6.84

1.8

2.0

0.86

0.85

nmol/l

0.09

192

2789

(40761535) Cells panel - Urine sediment

1351

11686

1.17

6.74

3.2

3.5

—

0.83

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

257

3586

0.71

6.72

2.8

3.7

406.55

882.09

u/ml

0.71

228

3266

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

315

4244

0.74

6.61

1.6

—

(3025130) Human papilloma virus identified in Specimen

344

2565

1.35

6.55

1.7

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

228

1586

1.44

6.55

1.7

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

908

7615

1.20

6.50

1.4

—

(3017569) Oxygen content in Arterial blood

871

0.44

6.48

2.2

2.4

16.21

15.95

0.21

871

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

134

2101

0.63

6.43

1.3

7.18

7.33

mmol/l

0.18

113

1863

(3029075) Extractable nuclear Ab panel - Serum

164

1075

1.53

6.34

1.1

—

0.33

—

(3002523) Influenza virus A Ag [Presence] in Specimen

381

2902

1.32

6.30

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

576

4627

1.25

6.27

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

151

2288

0.66

6.19

4.6

5.5

365.71

364.75

umol/l

0.03

119

2009

(40768797) Stomach Pathology biopsy report

2562

23272

1.12

6.14

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

461

1.80

6.10

2.6

3.2

1.94

1.91

ratio

0.04

418

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

334

4406

0.75

6.09

1.7

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

379

2900

1.31

6.08

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

165

1094

1.51

6.07

2.4

2.7

0.69

e9/l

0.07

160

1038

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

576

4646

1.25

6.06

2.1

12.34

11.44

mg/l

1.38

534

4363

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

652

5335

1.23

6.01

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1157

13365

0.86

5.99

2.0

2.5

0.38

0.40

e6/l

0.15

1071

12759

(3001893) Eosinophils/Leukocytes in Pleural fluid

426

0.23

5.93

1.3

1.4

1.50

2.45

—

369

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8455

81202

1.08

5.90

5.8

7.5

1.22

1.21

mmol/l

18.75

7500

70302

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1491

0.59

5.88

1.5

1.6

34.82

31.62

0.39

875

(21494755) Public health laboratory ask at order entry panel

1650

14630

1.14

5.87

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

142

2144

0.66

5.76

1.4

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

3245

0.72

5.71

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

757

0.43

5.70

4.0

4.1

—

(3030467) Casts [#/volume] in Urine by Automated count

4811

45219

1.09

5.69

3.3

0.29

0.40

e6/l

4.28

3215

33032

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

723

6017

1.21

5.66

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

289

3842

0.75

5.60

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

373

1.85

5.57

1.1

1.2

—

836.36

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

155

1037

1.50

5.51

1.3

157.68

175.83

pmol/l

0.81

155

1037

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

441

3490

1.27

5.50

2.0

1.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

151

1006

1.51

5.48

1.5

5.63

6.04

u/l

0.52

129

871

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

330

2517

1.32

5.46

1.2

3.30

3.92

u/ml

0.59

161

1168

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1473

13026

1.14

5.46

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

485

1.74

5.46

1.1

—

(3035880) pH of Pleural fluid

782

0.46

5.41

1.1

1.3

7.43

7.41

0.49

546

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

193

1353

1.43

5.41

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

441

3501

1.27

5.37

1.1

2.21

1.89

u/ml

0.25

242

1879

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3447

32013

1.10

5.30

2.8

3.1

2.44

2.45

mmol/l

6.23

3043

28860

(3009445) Proteinase 3 Ab [Units/volume] in Serum

836

7102

1.19

5.25

1.5

1.6

11.86

15.22

iu/ml

0.33

189

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

663

5516

1.21

5.24

1.7

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2137

19384

1.12

5.23

2.7

2.8

7.06

8.42

umol/l

2.78

1897

16912

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1405

0.60

5.21

1.8

1.4

1.00

1.26

promille

0.92

1090

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

242

1779

1.37

5.16

1.4

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1437

0.61

5.14

1.3

265.80

428.16

u/l

3.23

1373

(3045424) Erythrocytes [Presence] in Urine

951

8188

1.17

5.09

2.2

0.00

0.24

estimate

1.08

170

2635

(3029634) Reagin Ab [Titer] in Serum by VDRL

296

2250

1.32

5.06

1.9

2.1

3.63

8.08

titre

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

382

0.26

5.01

1.3

1.4

34.58

21.53

—

346

(3024891) Influenza virus A+B Ag [Presence] in Specimen

504

4101

1.24

4.97

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

337

1.84

4.96

1.1

32.34

31.63

iu/ml

0.04

337

(3022948) Iron [Moles/volume] in Serum or Plasma

2589

28119

0.91

4.93

2.3

2.7

14.27

13.20

umol/l

11.31

2444

26264

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

149

2.28

4.84

1.0

1.1

0.08

0.03

u/ml

0.49

149

(3023199) Leukocytes [#/volume] in Pleural fluid

125

1857

0.67

4.76

1.5

2907.70

3238.74

e6/l

0.09

1298

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5249

49804

1.08

4.73

2.1

2.2

154.89

201.83

u/l

8.90

4966

47100

(3003888) Timothy IgE Ab [Units/volume] in Serum

379

3009

1.27

4.67

1.1

4.02

4.77

u/ml

0.60

207

1577

(3020650) Glucose [Presence] in Urine

572

0.42

4.64

2.8

1.6

0.13

0.04

estimate

0.31

572

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

165

2.18

4.63

1.3

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.21

4.60

1.0

1.1

0.04

u/ml

0.12

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

275

2100

1.31

4.59

1.1

0.71

0.49

u/ml

0.25

699

(3041806) Other cells [#/volume] in Blood by Manual count

415

1.71

4.49

1.5

0.56

0.51

e9/l

1.10

415

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2402

26067

0.91

4.48

1.8

2.0

—

(3022475) Manganese [Moles/volume] in Blood

2.53

4.45

1.0

1.3

0.17

0.16

umol/l

0.22

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

647

5462

1.19

4.43

1.5

0.32

8.73

iu/ml

1.22

121

1027

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

268

3473

0.77

4.41

1.4

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1759

19356

0.90

4.31

1.6

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

496

4095

1.22

4.31

1.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

107

2.43

4.28

1.5

1.4

11.70

35.18

3.14

(3043410) Blood group antigens tested for on Red Blood Cells

408

0.34

4.28

1.5

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

1182

13296

0.88

4.24

2.4

3.5

4.60

4.56

kpa

0.23

1158

12949

(3010375) cycloSPORINE [Mass/volume] in Blood

739

0.51

4.23

27.2

29.9

116.06

115.01

ug/l

0.04

601

(3023430) Cat dander IgE Ab [Units/volume] in Serum

299

2338

1.28

4.21

1.1

3.80

4.87

u/ml

0.59

129

1038

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

111

738

1.51

4.17

1.6

1.7

29.96

29.29

umol/l

0.30

105

696

(40757373) Influenza virus identified in Isolate

289

0.31

4.17

1.1

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

525

4375

1.21

4.16

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

207

1.98

4.14

1.0

1.1

0.29

0.17

u/ml

0.23

132

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1082

9557

1.14

4.14

2.2

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

214

1.96

4.13

1.7

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

314

2478

1.27

4.12

1.1

3.58

3.98

u/ml

0.16

143

1222

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

439

3598

1.23

4.12

1.9

205.14

199.72

pmol/l

0.54

413

3409

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

426

5184

0.82

4.08

2.3

2.2

5286.55

5109.82

u/l

0.05

162

1977

(3023487) Leukocytes [#/volume] in Peritoneal fluid

648

0.49

4.05

1.8

2.0

833.40

2949.10

e6/l

0.80

433

(3042733) HLA Ab [Presence] in Serum

566

0.46

4.04

4.0

4.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

159

1143

1.39

3.99

2.5

2.7

227.70

235.34

e6/l

0.22

138

978

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

864

0.57

3.96

1.3

5.64

5.80

mmol/l

0.71

811

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

612

1.54

3.92

2.0

1.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

558

0.47

3.90

1.7

1.9

2681.62

13317.56

e6/l

1.62

281

(3002621) Streptococcal DNAse B [Units/volume] in Serum

151

2.12

3.88

1.0

1.1

169.80

370.85

u/ml

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1767

19325

0.90

3.85

1.7

1.8

—

(3045788) Cell count panel - Pleural fluid

102

1505

0.68

3.84

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

136

959

1.42

3.82

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

451

1.62

3.81

1.6

1.7

0.34

0.39

ug/l

0.60

339

(3003181) Sodium [Moles/volume] in Urine

233

3011

0.77

3.81

1.4

59.13

62.54

mmol/l

0.70

182

2407

(3004446) Plasmodium sp identified in Blood by Light microscopy

146

2.13

3.79

2.1

2.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

165

1205

1.37

3.78

1.4

10.53

12.55

umol/l

5.78

155

1136

(3008401) Mugwort IgE Ab [Units/volume] in Serum

359

2910

1.24

3.77

1.1

0.59

1.05

u/ml

2.30

161

1288

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

236

1.87

3.76

1.6

2.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

112

764

1.47

3.76

1.6

1.8

2.02

1.96

umol/l

0.35

100

705

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

339

1.71

3.74

1.2

339.28

323.14

pmol/l

0.06

251

(3028308) Erythrocytes [#/volume] in Pleural fluid

114

1637

0.69

3.72

1.4

1.5

35452.78

56185.53

e6/l

0.92

902

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

364

0.36

3.71

1.1

—

37.73

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

236

0.30

3.70

9.9

11.0

5.09

5.29

mmol/l

—

236

(3051101) Glucose [Moles/volume] in Cord blood

239

0.29

3.69

3.0

6.1

6.97

8.49

mmol/l

—

239

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2432

26149

0.92

3.67

2.3

2.6

2.37

2.35

g/l

1.15

2254

24235

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1322

0.66

3.65

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

474

0.44

3.63

3.0

3.7

43.21

52.90

1.10

460

(3042936) Bacteria identified in Isolate by Culture

2145

23175

0.92

3.61

1.7

2.1

—

(3003129) Base excess in Capillary blood by calculation

248

1936

1.29

3.61

2.0

2.3

0.64

0.57

mmol/l

0.12

242

1870

(3010726) Horse dander IgE Ab [Units/volume] in Serum

348

2829

1.23

3.58

1.1

1.37

1.62

u/ml

0.26

174

1445

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

696

6027

1.16

3.57

1.9

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

214

1642

1.31

3.55

1.2

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

120

1692

0.71

3.55

1.0

1.2

—

33.88

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

100

676

1.48

3.54

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

263

0.34

3.53

1.0

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

381

0.39

3.48

3.1

2.4

6.60

101.02

ug/l

0.68

381

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

148

2005

0.74

3.43

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

196

1496

1.31

3.40

1.4

41443.56

128889.17

e6/l

2.84

131

998

(3001186) Copper [Moles/volume] in Serum or Plasma

442

1.59

3.39

1.4

1.3

17.44

16.72

umol/l

0.63

382

(40768806) Pleura Pathology biopsy report

112

1576

0.71

3.30

1.5

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

428

0.44

3.30

5.9

7.5

6.15

5.96

kpa

0.53

384

(3035947) Staphylolysin Ab [Units/volume] in Serum

110

770

1.43

3.28

1.1

3.83

3.77

iu/ml

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

714

1.45

3.24

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

714

1.45

3.24

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5863

56401

1.06

3.22

3.3

3.6

2.37

2.36

mmol/l

8.61

5080

51544

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

227

2875

0.79

3.22

1.8

1.7

—

(3024316) Viscosity of Plasma

2.44

3.20

1.1

1.8

1.51

1.58

mpas

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

179

1362

1.32

3.20

1.1

295.97

290.76

mg/l

0.37

161

1234

(3039162) Centromere protein B Ab [Units/volume] in Serum

275

2212

1.25

3.17

1.2

1.3

76.98

61.71

u/ml

—

140

(21494434) Karyotype in Bone marrow

181

1382

1.31

3.16

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

889

7903

1.13

3.15

2.1

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

149

1108

1.35

3.12

2.2

2.5

461.98

522.97

e6/l

1.11

125

893

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1481

16158

0.91

3.10

2.4

2.3

379.14

376.61

nmol/l

0.19

1369

15014

(3008116) Ketones [Moles/volume] in Urine by Test strip

366

1.61

3.10

1.2

1.5

0.27

0.31

mmol/l

0.10

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

181

0.28

3.09

1.6

1.2

5.24

5.96

mmol/l

—

181

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

101

1424

0.71

3.05

1.3

9.73

8.72

mmol/l

1.26

1344

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2253

24118

0.92

3.05

2.3

2.7

23.99

22.64

5.25

2128

22453

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

203

2583

0.78

3.02

1.1

78.98

5134.48

iu/ml

0.66

542

(3005322) IgE [Units/volume] in Serum or Plasma

1235

11227

1.11

2.97

1.3

185.25

246.28

u/ml

1.50

1164

10440

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

562

1.48

2.97

1.6

2.1

9.41

9.11

mg/l

0.18

469

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

808

0.62

2.97

1.3

1.9

162.85

129.06

umol/l

0.23

402

(3034988) Calcium [Moles/volume] in Capillary blood

282

0.35

2.97

6.6

2.1

1.17

1.18

mmol/l

—

267

(3027923) C peptide [Moles/volume] in Serum or Plasma

953

0.65

2.95

1.8

1.5

1.27

1.24

nmol/l

0.06

727

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

127

1715

0.74

2.94

1.4

1.3

1.40

1.48

nmol/l

0.27

106

1547

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

557

4824

1.16

2.92

2.5

178.71

193.05

4.03

525

4584

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

228

1815

1.26

2.91

1.1

99.06

96.74

0.72

210

1708

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

405

0.47

2.89

1.1

1.3

53.09

40.32

0.61

270

(3052851) Hemolysis interference index of Serum or Plasma

516

4447

1.17

2.89

2.7

3.1

3.19

2.31

index

0.42

243

2253

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1283

11713

1.10

2.85

1.2

157.60

139.03

u/ml

0.79

442

4525

(3018418) pH of Serum or Plasma

4731

49281

0.94

2.80

3.7

4.4

7.40

1.64

3035

35218

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

301

0.40

2.77

7.8

6.6

10.65

10.49

0.10

301

(44806118) Parainfluenza type 4 nucleic acid detection

169

2172

0.78

2.76

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

169

2172

0.78

2.76

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

169

2172

0.78

2.76

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

169

2172

0.78

2.76

1.4

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

122

899

1.36

2.76

2.4

2.2

5.37

3.58

ug/l

0.91

112

837

(3024666) Lithium [Moles/volume] in Serum or Plasma

949

0.66

2.75

11.2

13.7

0.60

0.63

mmol/l

0.57

865

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1183

0.70

2.71

1.8

1.9

1.03

1.79

u/field

1.44

654

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1377

12648

1.10

2.71

1.4

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

309

2567

1.21

2.68

1.2

3.00

3.38

u/ml

0.20

112

944

(3048929) Epstein Barr virus Ab [Presence] in Serum

586

5132

1.15

2.67

1.2

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

568

1.45

2.66

1.3

1.2

108.64

110.38

0.26

508

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

122

905

1.35

2.66

1.1

1562.89

1543.19

miu/ml

0.06

122

905

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

350

1.57

2.65

1.2

1.1

102.10

78.94

—

107

(3024471) HLA-A [Type]

535

0.56

2.65

1.0

—

(3001556) Androgen free Index in Serum or Plasma

119

2.02

2.65

1.6

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

201

1597

1.26

2.65

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

172

1342

1.28

2.63

1.1

1.2

350.00

143.57

titre

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

279

0.39

2.62

4.1

2.1

1.19

mmol/l

0.06

268

(3025577) Chromium [Mass/volume] in Blood

118

873

1.35

2.62

2.3

2.2

3.25

2.37

ug/l

0.87

728

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

172

1344

1.28

2.60

1.1

1.2

183.93

200.40

titre

0.10

227

(3044007) Cell count panel - Peritoneal fluid

544

0.57

2.59

1.7

1.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

309

3691

0.83

2.58

4.2

6.0

481.22

1444.80

iu/ml

1.20

549

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

287

2377

1.21

2.58

1.1

121.88

117.61

1.41

255

2155

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

523

1.46

2.56

1.2

1.1

90.67

88.88

0.15

240

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

297

2470

1.21

2.56

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

598

1.42

2.55

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

598

1.42

2.55

2.1

2.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

114

2.02

2.55

1.0

1.2

0.49

0.67

iu/ml

0.41

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

135

1026

1.32

2.52

1.2

1.3

66.25

63.65

titre

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

395

1.52

2.51

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

383

0.50

2.51

5.9

7.3

5.04

5.45

kpa

0.83

383

(4195642) Thrombophilia screening test

286

2375

1.21

2.51

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.27

2.50

1.0

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

348

1.55

2.49

1.2

62.88

72.27

—

101

(3016244) Insulin [Units/volume] in Serum or Plasma

129

978

1.32

2.46

3.5

3.3

21.87

26.41

mu/l

1.00

120

926

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

521

1.44

2.43

1.1

1.0

5.66

10.84

u/ml

2.43

330

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

480

1.46

2.42

1.1

1.3

146.49

129.21

nmol/l

0.48

350

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

605

1.41

2.41

2.1

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

214

1734

1.24

2.41

1.6

1.8

307.96

359.85

mu/l

2.81

174

1364

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

339

2874

1.18

2.39

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

176

0.34

2.39

2.0

2.5

0.50

0.60

u/field

—

176

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

440

0.54

2.37

1.3

1.2

4.15

11.72

pmol/l

—

162

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.25

2.37

1.0

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

217

1765

1.23

2.36

3.7

3.5

54.63

57.20

1.03

192

1533

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

608

1.40

2.35

1.4

1.2

0.30

g/l

0.09

488

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

106

787

1.35

2.34

2.4

1.9

137.70

152.04

1.19

100

740

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

122

925

1.32

2.34

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

517

1.43

2.34

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

188

1508

1.25

2.33

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

414

3579

1.16

2.30

1.5

1.4

—

(3024932) HLA-DR beta [Type]

524

0.59

2.30

1.1

—

(3000492) Spirometry study

1753

16389

1.08

2.29

1.5

—

20.46

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

230

1.65

2.28

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

148

1158

1.28

2.26

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

488

5556

0.87

2.25

2.5

2.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

136

1054

1.29

2.24

1.2

1.3

20.00

540.96

titre

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

423

1.47

2.23

1.4

1.7

49.58

136.61

au/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

146

1144

1.28

2.22

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5910

57317

1.05

2.20

3.4

3.5

1.23

2.06

e6/l

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.86

2.20

1.0

1.1

2.50

3.14

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

112

848

1.32

2.19

1.3

4.15

4.47

umol/l

0.56

751

(3027231) Wheat IgE Ab [Units/volume] in Serum

312

1.54

2.17

1.0

1.1

1.04

1.76

u/ml

0.27

266

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

976

10656

0.91

2.15

3.2

3.8

5.09

5.15

kpa

2.02

920

10217

(3002719) Hemoglobin [Mass/volume] in Urine

3.69

2.15

1.0

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

152

0.33

2.12

1.6

1.4

11.30

16.75

pmol/l

—

127

(21494815) CD4 cells/Lymphocytes in Specimen

174

1401

1.24

2.12

1.9

2.3

42.01

39.09

1.82

169

1373

(3013826) Glucose [Moles/volume] in Serum or Plasma

9167

93510

0.96

2.11

4.2

5.2

6.40

6.67

mmol/l

40.86

8695

88790

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

682

0.66

2.11

3.1

3.4

1.59

1.33

0.53

682

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

296

2514

1.18

2.09

1.4

28.92

31.21

u/l

0.51

235

2048

(4268621) Lupus anticoagulant assay

221

1829

1.21

2.08

2.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

291

0.48

2.08

2.9

11.56

40.50

mg/l

—

(4038314) Semen analysis, post vasectomy

2.13

2.08

1.1

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.56

2.07

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.56

2.07

1.0

1.1

0.19

0.22

g/l

0.89

(3015171) Extractable nuclear Ab [Units/volume] in Serum

757

6855

1.11

2.06

1.3

0.41

1.06

u/ml

2.22

565

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

231

2765

0.83

2.05

1.5

1.3

32.83

30.57

u/l

0.13

200

2390

(3024980) IgG subclass 4 [Mass/volume] in Serum

345

2972

1.16

2.05

1.6

0.74

0.75

g/l

0.07

289

2298

(40768793) Breast Pathology biopsy report

484

4272

1.14

2.05

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

124

964

1.29

2.03

1.0

1.1

2.18

6.08

u/ml

0.45

243

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

516

1.40

2.02

1.4

1.1

89.23

90.51

0.07

243

(3002331) Protein [Mass/volume] in Peritoneal fluid

392

0.56

2.02

1.1

1.4

29.76

25.13

g/l

0.71

301

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.22

2.00

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

147

1170

1.26

2.00

1.1

—

0.57

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

271

1.55

1.99

1.1

1.59

9.15

u/ml

1.43

179

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1275

0.76

1.99

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

163

2010

0.81

1.97

1.9

2.5

1.06

1.23

g/24h

0.27

1202

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

829

1.30

1.96

1.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

124

1575

0.79

1.95

1.8

2.0

—

0.86

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

194

1.65

1.95

1.1

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1552

14542

1.07

1.95

6.1

8.1

1.27

1.33

mmol/l

0.97

1508

14287

(3022725) Serotonin [Moles/volume] in Serum

2.19

1.94

1.5

1.3

436.29

953.68

nmol/l

1.26

(3036670) Protein [Mass/volume] in Synovial fluid

487

1.40

1.93

1.3

39.03

39.75

g/l

0.13

255

(3013336) Amino acids [Identifier] in Serum or Plasma

2.73

1.93

1.4

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

200

2408

0.83

1.92

1.3

291.97

371.91

pmol/l

0.91

182

2055

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

135

1.78

1.90

1.1

1.3

19.96

14.82

nmol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

617

1.35

1.89

1.1

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

1.88

0.0

2.5

—

4.40

—

(3036489) Thrombin time

686

6216

1.11

1.88

1.9

2.1

20.47

21.08

2.17

607

5471

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.15

1.87

1.0

1.4

—

(3048879) Bone marrow aspiration report

398

1.43

1.87

2.1

2.0

—

2.00

—

(40768800) Prostate Pathology biopsy report

325

2815

1.16

1.84

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

2033

0.82

1.81

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

416

0.60

1.81

1.1

1.3

2.27

268.75

ug/l

2.54

226

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

519

1.37

1.81

1.1

1.2

1100.00

970.75

titre

0.43

106

(3027456) Digoxin [Moles/volume] in Serum or Plasma

233

2749

0.85

1.80

3.5

3.2

0.73

0.81

nmol/l

2.73

180

2206

(3024869) Neuronal Ab [Presence] in Serum

311

1.48

1.79

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

825

8986

0.91

1.78

3.0

3.7

1.39

1.78

mmol/l

3.26

621

6702

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3184

30576

1.05

1.77

3.6

3.9

314.99

432.01

ng/l

1.17

2415

23278

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

146

1.71

1.77

1.0

1.1

2.07

1.66

iu/ml

0.56

(3008295) Osmolality of Serum or Plasma

146

1793

0.81

1.74

1.8

1.4

278.97

278.68

mosm/kgh2o

0.05

1365

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.93

1.74

1.1

1.0

2.06

0.27

u/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

248

2901

0.85

1.74

2.6

2.8

529.62

2964.44

u/ml

1.03

153

(3044927) Protein electrophoresis panel - Urine

180

1491

1.21

1.74

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

124

987

1.26

1.73

1.0

1.1

0.96

1.96

u/ml

0.71

325

(3015076) Soybean IgE Ab [Units/volume] in Serum

112

881

1.27

1.73

1.0

1.1

0.30

1.62

u/ml

1.05

220

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.85

1.71

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.70

0.0

8.4

—

(4024509) Urine culture

815

7491

1.09

1.69

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

195

1633

1.20

1.69

3.8

3.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

694

0.71

1.68

3.0

4.9

4688.50

891.31

mg/l

0.38

500

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

477

4269

1.12

1.67

1.1

4.71

7.28

eliau/ml

0.83

531

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2552

24413

1.05

1.66

1.6

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

220

2584

0.85

1.64

1.3

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

441

0.63

1.64

1.2

1.3

2.95

3.46

mmol/l

0.69

405

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

146

0.41

1.63

1.5

1.3

21.23

21.05

mmol/l

—

114

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

239

0.50

1.63

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

310

2706

1.15

1.62

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

245

1.51

1.61

2.4

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

106

1.79

1.58

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

121

1.74

1.57

1.1

1.2

—

(3009343) pH of Capillary blood

962

10345

0.93

1.56

3.2

3.8

7.42

4.29

753

8634

(3027570) Oxalate [Moles/time] in 24 hour Urine

100

1.80

1.52

1.2

1.5

350.83

307.10

umol/24h

0.56

100

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

764

1.27

1.52

1.2

10.06

10.30

mm/h

0.07

764

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

1.52

0.0

1.3

—

132.75

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

112

1389

0.81

1.51

1.9

2.6

757.94

1071.58

1.82

112

1375

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

358

0.61

1.50

1.2

1.3

1.20

1.18

mmol/l

0.53

358

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

131

1.68

1.49

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

849

0.75

1.48

1.5

1.7

3.86

7.18

nmol/l

0.42

697

(3011048) Pyruvate [Moles/volume] in Blood

1.81

1.46

1.6

1.2

69.53

80.89

umol/l

0.89

(40761539) Cells [Type] in Urine sediment by Light microscopy

379

0.63

1.45

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.84

1.45

1.1

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

132

1.67

1.45

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

581

0.70

1.45

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

662

0.72

1.45

3.5

1.7

7889.40

350.51

pmol/l

0.46

109

(3002582) Erythrocytes [#/volume] in Urine

5358

52246

1.04

1.44

3.3

3.4

66.54

75.83

e6/l

0.14

3789

39822

(37021550) Renin [Units/volume] in Plasma --upright

310

1.42

1.44

1.3

93.41

93.84

mu/l

0.00

232

(3029612) Listeria sp Ab [Titer] in Serum

2.73

1.43

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.03

1.43

1.1

—

(40768446) Kidney Pathology biopsy report

695

0.73

1.43

1.3

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

220

1.50

1.42

1.1

—

(3006270) Folate [Moles/volume] in Blood

140

1159

1.21

1.42

1.2

1.1

385.44

367.99

nmol/l

0.45

131

997

(3032352) Blasts [#/volume] in Cerebral spinal fluid

180

1.56

1.42

2.1

2.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

133

1.65

1.42

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

362

3229

1.12

1.40

1.8

1.9

5.28

5.08

mmol/24h

0.53

315

2892

(3014148) Varicella zoster virus Ab [Titer] in Serum

255

2225

1.15

1.39

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

100

802

1.25

1.37

4.2

6.2

11766.80

5328.53

u/ml

—

136

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.00

1.37

1.0

1.1

4.99

0.50

u/ml

0.43

(3020491) Glucose [Moles/volume] in Blood

132

1091

1.21

1.37

1.4

1.8

6.28

6.72

mmol/l

2.00

110

759

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

161

0.50

1.35

1.1

1.2

—

0.45

—

(3014891) Appearance of Pleural fluid

163

0.49

1.35

2.0

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

144

1203

1.20

1.34

1.1

1.2

77.80

81.99

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.75

1.34

1.1

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.34

0.0

8.6

—

51.69

—

(4198724) Urine methamphetamine measurement

675

0.74

1.34

1.6

2.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1111

11806

0.94

1.33

1.6

1.7

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

257

0.58

1.29

1.9

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

133

0.45

1.27

1.0

1.1

—

18.40

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

1378

1.18

1.25

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

475

1.31

1.25

2.0

2.2

0.18

0.49

e9/l

1.01

227

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

582

1.27

1.23

1.1

—

(3011412) CD3 cells [#/volume] in Blood

184

1585

1.16

1.23

2.2

2.4

1209.47

1198.91

e6/l

0.07

162

1399

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

573

0.73

1.22

2.7

3.2

27.60

28.34

umol/l

0.08

433

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

262

1.41

1.22

1.3

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.63

1.21

1.2

1.0

4500.00

2913.68

titre

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

227

0.57

1.21

1.2

2.3

0.51

1.10

mmol/l

—

154

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

252

0.59

1.21

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

560

6078

0.92

1.21

3.5

3.7

431.35

1731.81

u/ml

1.75

485

5249

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

943

0.79

1.20

1.2

1.1

—

(4212803) Bone marrow aspirate examination

132

1.59

1.20

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

166

1422

1.17

1.19

1.2

122.39

109.28

pmol/l

1.03

166

1422

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

164

1.53

1.19

1.0

0.00

2.84

u/ml

0.55

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2362

24515

0.96

1.19

2.0

2.2

29.32

29.54

1.16

2321

23872

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

787

8422

0.93

1.19

2.1

3.2

1.14

1.26

3.70

781

8382

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

230

1.44

1.19

1.1

1.0

12.35

7.95

u/ml

0.26

230

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

374

3381

1.11

1.18

1.2

1.4

9.01

25.45

u/ml

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

116

965

1.20

1.17

2.0

2.2

100.50

98.20

0.33

108

901

(3045142) Bone marrow Pathology biopsy report

213

1863

1.15

1.17

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.70

1.17

1.1

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1399

13313

1.06

1.16

2.8

2.7

72.40

67.43

ml/min/173m2

5.93

540

5557

(3011436) Histone Ab [Units/volume] in Serum

350

1.34

1.16

1.1

—

21.20

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1420

13523

1.05

1.15

2.6

2.7

66.87

66.43

g/l

1.67

1278

12481

(3019174) dRVVT (LA screen)

134

1.57

1.14

1.2

—

(40768795) Lymph node Pathology biopsy report

151

1762

0.86

1.14

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

369

1.33

1.13

1.1

1.2

—

(4034850) Laboratory test

527

4857

1.09

1.13

7.9

9.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

103

1.65

1.12

4.7

6.0

—

(3003694) ABO and Rh group [Type] in Blood

4464

45721

0.97

1.11

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1958

18817

1.05

1.11

1.5

1.6

—

(3036603) Volume of Urine

151

1294

1.17

1.10

1.7

1.6

2045.49

1972.79

0.51

151

1261

(3000330) Specific gravity of Urine by Test strip

826

7752

1.07

1.10

2.9

3.3

1.02

ratio

2.03

713

6992

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

176

1528

1.15

1.09

3.6

3.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

218

2468

0.88

1.08

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

173

1988

0.87

1.08

1.5

1.6

46.97

57.10

2.81

123

1218

(3017509) Phencyclidine [Presence] in Urine

165

0.55

1.07

1.6

1.4

—

(3011985) Renin [Units/volume] in Plasma

230

2593

0.89

1.07

1.5

64.27

63.01

mu/l

0.03

204

2329

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

1440

0.85

1.07

2.8

3.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

205

2326

0.88

1.06

2.9

2.7

4.98

825.03

u/ml

1.29

205

2304

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

219

1.42

1.06

1.2

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.65

1.06

3.6

3.8

—

0.00

estimate

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

161

1.49

1.06

1.0

0.01

0.45

u/ml

0.91

(3042111) Morphology [Interpretation] in Bone marrow Narrative

238

2674

0.89

1.05

1.5

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

492

5330

0.92

1.05

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

623

5801

1.08

1.05

1.8

2.3

170.34

582.53

ug/l

10.16

573

5495

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.71

1.05

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

305

1.35

1.04

1.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

111

1316

0.84

1.04

2.1

2.3

19.09

18.10

nmol/l

0.57

106

1241

(3034274) Bile acid [Moles/volume] in Serum --fasting

197

1732

1.14

1.03

2.0

2.1

5.29

8.37

umol/l

3.11

141

1269

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

373

3404

1.10

1.02

1.2

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

1092

1.17

1.01

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

201

1774

1.13

1.00

1.1

0.89

1.94

iu/ml

—

(3028433) Virus identified in Specimen by Culture

510

1.26

1.00

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.2

1.1

28.09

62.57

umol/24h

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

995

0.82

0.99

1.2

1.1

16.27

23.55

u/l

2.06

887

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

201

0.60

0.99

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

440

4053

1.09

0.99

1.9

3.5

61.02

62.00

0.42

431

3922

(3009677) Dengue virus Ab [Presence] in Serum

1.80

0.98

1.2

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.17

0.98

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.17

0.98

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.17

0.98

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

0.98

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.17

0.98

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.17

0.98

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.17

0.98

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

158

0.57

0.98

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

530

1.25

0.97

1.1

1.3

3.90

26.38

5.75

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

682

7271

0.94

0.97

1.7

1.35

1.56

g/l

8.57

572

6291

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1003

0.83

0.97

1.2

1.1

76.70

82.52

u/l

0.47

891

(40757494) Bilirubin.total [Moles/volume] in Blood

805

0.81

0.97

1.8

2.2

37.80

37.14

umol/l

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

565

5263

1.08

0.96

1.4

284.33

274.98

ug/g

0.51

306

3054

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1204

12619

0.95

0.96

2.0

2.3

7.84

7.64

ug/l

0.10

1023

11207

(3033086) Enterovirus Ab [Titer] in Serum

1.80

0.96

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.5

—

437.55

—

(21494890) Protein electrophoresis panel - 24 hour Urine

144

1659

0.87

0.96

2.0

2.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

284

1.34

0.96

1.0

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

604

1.23

0.95

1.2

0.09

0.22

g/l

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

1.6

—

1714.25

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

832

1.19

0.95

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

832

1.19

0.95

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

832

1.19

0.95

2.0

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

322

2932

1.10

0.94

3.4

3.8

30.94

35.72

u/ml

0.24

312

2839

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

285

1.33

0.94

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

285

1.33

0.94

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

843

7969

1.06

0.93

1.1

160.75

204.67

titre

0.36

224

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

303

1.32

0.93

1.8

1.4

15058.33

270038.44

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

834

1.19

0.93

2.0

1.9

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

799

0.81

0.91

1.1

1.3

94.08

64.18

6.57

(3017732) Neutrophils [#/volume] in Blood

2184

21135

1.04

0.91

3.0

3.2

4.25

4.42

e9/l

0.42

1646

18472

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

151

1.46

0.90

1.0

0.09

0.60

u/ml

1.00

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

958

0.83

0.87

1.1

1.04

1.06

ratio

1.95

793

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

194

1.39

0.87

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

556

5201

1.07

0.87

2.1

2.3

94.61

93.16

0.94

537

5009

(3000093) Morphology [Interpretation] in Blood Narrative

172

1521

1.13

0.87

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

103

1.55

0.87

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.86

0.87

1.3

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

246

1.34

0.86

1.8

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

583

0.79

0.86

1.4

14.59

15.38

pmol/l

0.57

483

(3042517) Benzodiazepines panel - Urine

180

0.61

0.85

1.2

2.5

—

(40758292) HTLV I+II Ab panel - Serum

317

1.29

0.84

1.3

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.94

0.84

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

104

1.54

0.84

1.3

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

203

0.64

0.84

1.2

1.1

—

(4133840) Spirometry

412

0.75

0.83

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

660

1.20

0.83

1.7

1.4

37.65

34.29

nmol/l

0.40

586

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

479

1.23

0.82

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

205

2281

0.90

0.82

1.5

24.58

29.72

ng/l

1.78

205

2274

(3025941) Bacteria identified in Stool by Culture

935

8909

1.05

0.81

1.2

—

(4035726) Immunohistochemistry procedure

1528

14728

1.04

0.81

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

355

1.27

0.81

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

130

1.46

0.80

1.4

1.6

0.69

1.61

mg/l

1.42

(3024263) Appearance of Synovial fluid

792

1.18

0.80

1.6

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

205

1844

1.11

0.80

1.4

6.40

6.78

g/l

0.97

168

1324

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

572

1.21

0.80

3.4

3.6

8.64

8.57

mg/l

0.03

461

(3045177) Copper [Moles/volume] in Urine

0.00

0.79

0.0

1.1

—

0.52

—

(40765089) Chromosome analysis panel - Blood by G-banded

402

1.24

0.77

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

204

1842

1.11

0.75

1.4

0.36

0.41

g/l

1.98

168

1321

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

725

0.83

0.75

1.9

2.1

26.72

135.30

ug/min

2.22

163

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5861

59492

0.98

0.74

3.3

3.7

44.92

62.05

ng/l

0.57

3829

40324

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.08

0.74

1.0

2.79

0.51

u/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2491

25567

0.97

0.74

1.6

1.7

1046.94

1163.77

nmol/l

8.49

1722

19559

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.84

0.73

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

626

1.18

0.71

2.5

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

8508

85980

0.98

0.71

3.5

3.9

10.07

3.29

estimate

0.97

910

18312

(3016038) Potassium [Moles/volume] in Urine

1085

0.87

0.70

1.2

41.62

34.35

mmol/l

1.64

951

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

500

0.80

0.70

1.1

1.6

—

173.63

—

(3004809) Band form neutrophils/Leukocytes in Blood

251

2736

0.92

0.70

3.6

3.5

1.66

1.58

0.10

227

2482

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

517

1.20

0.70

2.5

2.7

38.84

148.11

au/ml

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

545

1.19

0.69

1.1

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

203

1843

1.10

0.69

1.4

2.86

2.92

g/l

0.22

168

1326

(3024561) Albumin [Mass/volume] in Serum or Plasma

7182

72694

0.98

0.69

4.2

5.3

36.92

35.83

g/l

63.73

6717

68428

(3026726) Creatinine [Moles/volume] in Specimen

143

0.63

0.69

1.3

2.6

527.22

388.59

umol/l

—

137

(3009214) Lutropin [Units/volume] in Serum or Plasma

477

4486

1.07

0.69

1.4

10.74

11.06

u/l

0.18

377

3576

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

140

1570

0.89

0.69

1.2

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

342

0.76

0.68

6.5

4.8

58.31

56.71

u/l

0.02

333

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.68

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

239

1.30

0.68

1.0

78.20

78.85

ug/l

0.03

189

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

267

2898

0.92

0.68

1.3

—

14.60

—

(3037756) Immunofixation for Serum or Plasma

309

3329

0.93

0.66

1.9

1.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

321

1.25

0.66

1.5

1.9

3.70

3.02

ug/l

0.16

190

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

108

1225

0.88

0.65

1.9

2.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.72

0.64

1.0

0.03

0.05

u/ml

—

(4062490) Immunoglobulin typing, IgG

198

1809

1.10

0.62

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

333

1.23

0.62

1.2

1.1

2.48

0.66

umol/24h

0.47

154

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

102

0.59

0.62

1.7

1.2

27.00

1490.73

u/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1906

19575

0.97

0.61

1.6

1.8

1.38

1.45

5.27

1669

17126

(3001964) Herpes simplex virus Ag [Presence] in Specimen

452

1.20

0.61

1.3

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

635

6050

1.05

0.61

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

876

8412

1.04

0.60

1.4

30.86

29.73

iu/l

0.44

746

7188

(3020717) Zinc [Moles/volume] in Serum or Plasma

112

994

1.13

0.60

1.4

1.5

30.33

23.63

umol/l

1.18

101

922

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.2

—

0.53

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

196

1794

1.09

0.60

2.4

36.24

25.99

iu/ml

0.40

197

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

444

4700

0.94

0.59

1.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

1.3

—

107.89

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

109

1225

0.89

0.58

1.7

1.8

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.67

0.56

1.0

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1069

10330

1.04

0.55

1.9

1.36

1.30

g/l

0.40

975

9543

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

124

1.37

0.55

1.4

1.6

4.57

3.99

mg/l

0.14

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

124

1.37

0.55

1.4

1.6

2.03

1.83

mg/l

0.09

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

124

1.37

0.55

1.4

1.6

0.72

0.66

mg/l

0.07

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

311

1.22

0.55

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

127

1146

1.11

0.53

1.0

775.33

739.61

ng/l

0.35

807

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

358

1.20

0.53

1.1

—

(3013762) Body weight Measured

1.54

0.53

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

329

3094

1.06

0.52

1.2

1.5

146.57

151.39

au/ml

0.35

123

862

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

1081

1.11

0.52

1.2

1.3

16.75

22.96

u/l

1.78

895

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

127

1149

1.11

0.52

1.0

38.42

41.87

ng/l

0.55

827

(44816559) Phosphatidylethanol [Mass/volume] in Blood

666

6940

0.96

0.51

1.7

0.28

0.31

mg/l

0.85

287

3292

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

109

1.38

0.50

1.0

1.1

7.53

11.22

u/l

0.76

109

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

1199

1.10

0.50

1.4

1.5

23.00

24.10

u/ml

0.08

221

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

118

1.36

0.50

1.0

1.1

0.02

0.21

u/ml

1.81

118

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

340

3601

0.94

0.50

1.5

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

126

1143

1.10

0.49

1.0

290.27

328.02

ng/l

1.21

837

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1669

17103

0.97

0.49

3.9

4.4

12.13

24.90

ug/l

1.32

1279

13894

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

346

3268

1.06

0.49

1.2

1.3

252.10

266.86

u/ml

0.42

225

2040

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

482

1.16

0.49

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

482

1.16

0.49

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

482

1.16

0.49

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

482

1.16

0.49

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

101

1.39

0.49

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

225

1.24

0.49

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

145

1.31

0.48

1.1

102.74

94.01

titre

0.13

145

(3011841) English Walnut IgE Ab [Units/volume] in Serum

163

1.29

0.48

1.0

1.1

5.33

5.16

u/ml

0.01

128

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

273

2564

1.07

0.47

1.6

1.4

0.32

0.37

nmol/l

0.99

209

1887

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

270

2535

1.07

0.47

1.3

0.58

2.42

nmol/l

1.30

256

2447

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.47

0.47

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

168

1551

1.08

0.46

4.7

5.4

38.09

101.45

u/ml

3.43

506

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

318

3006

1.06

0.45

1.2

497.67

299.64

titre

0.41

236

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

118

0.68

0.45

2.4

5.8

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.43

0.45

1.0

0.02

0.07

u/ml

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

864

1.11

0.45

1.2

303.81

380.48

u/l

0.38

792

(3027945) Reticulocytes/Erythrocytes in Blood

1773

18120

0.98

0.44

2.3

2.6

1.66

1.79

8.05

1555

16277

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

121

1104

1.10

0.44

1.2

1.3

77.34

88.17

u/l

0.97

104

933

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

989

0.90

0.44

2.9

2.8

41.06

38.88

0.43

551

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.41

0.43

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

235

2208

1.07

0.42

1.3

0.26

0.20

nmol/l

0.35

180

1716

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

139

0.72

0.41

1.7

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

680

0.88

0.41

1.0

1.1

103.58

95.73

1.08

543

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

109

994

1.10

0.41

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

488

5086

0.96

0.41

1.3

220.93

221.82

miu/ml

0.02

239

2283

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.1

—

293.27

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.41

0.0

1.2

—

36.42

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.41

0.0

2.5

—

8.68

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

182

1698

1.07

0.41

1.7

1.4

3.55

3.89

ug/l

0.27

158

1429

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

150

1389

1.08

0.41

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

150

1389

1.08

0.41

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

150

1389

1.08

0.41

1.8

1.7

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

69.04

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

313

2975

1.05

0.39

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

313

2975

1.05

0.39

1.2

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

101

0.69

0.39

2.0

2.1

0.59

0.60

ug/l

—

101

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

101

0.69

0.39

5.7

5.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

792

0.90

0.39

1.5

1.8

0.88

2.86

u/field

4.85

568

(3008536) Aspergillus sp Ab [Presence] in Serum

345

0.84

0.38

3.1

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

666

1.11

0.37

2.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

112

0.71

0.37

1.5

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1050

0.91

0.37

1.6

1.5

7.49

6.67

u/l

0.24

830

(40758358) Immune stain study

1.29

0.36

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

1378

14075

0.98

0.35

2.3

2.6

66.57

70.28

e9/l

3.89

955

10360

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

754

0.90

0.35

1.1

8.90

12.35

u/ml

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

130

1209

1.08

0.34

3.8

3.6

101.84

162.25

nmol/l

1.80

130

1197

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

129

1386

0.93

0.34

1.5

1.8

3.24

3.84

mg/l

1.98

123

1335

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.34

0.34

14.6

8.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

140

1307

1.07

0.33

1.0

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

8708

86570

1.01

0.33

3.6

4.0

0.00

0.29

estimate

1.86

871

17352

(3012494) Peanut IgE Ab [Units/volume] in Serum

425

0.87

0.33

1.1

0.87

11.87

u/ml

0.78

239

(3013466) aPTT in Blood by Coagulation assay

0.70

0.33

1.2

1.1

35.57

36.59

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.68

0.33

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

339

0.86

0.33

2.7

2.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1030

0.92

0.32

6.7

7.0

43.58

97.74

ug/l

0.54

666

(3025549) Creatine [Moles/time] in 24 hour Urine

132

0.76

0.32

1.6

1.4

—

14.73

—

(3000991) Gas panel - Venous blood

1440

14130

1.02

0.31

7.1

9.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

1011

1.08

0.31

1.4

—

(3027008) Opiates [Presence] in Urine

629

6107

1.03

0.31

1.6

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

685

0.90

0.31

1.1

1.2

—

(3017704) Immunofixation for Urine

809

0.91

0.30

1.9

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

504

1.11

0.30

1.0

0.34

0.68

u/ml

0.80

492

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

129

1.24

0.30

1.8

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1124

11009

1.02

0.30

3.2

3.5

4.52

4.47

pmol/l

1.09

974

9925

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

413

3986

1.04

0.30

1.4

1.5

106.41

153.99

pmol/l

1.78

404

3886

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

111

1.26

0.30

1.3

0.87

1.08

ml/s/173m2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

470

4855

0.97

0.29

3.4

3.3

3.36

4.36

ratio

0.26

257

2772

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

271

2595

1.05

0.29

1.3

0.14

0.23

nmol/l

1.50

176

(3016273) Islet cell 512 Ab [Units/volume] in Serum

106

0.75

0.29

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

108

0.74

0.29

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1583

16094

0.98

0.29

2.4

2.3

0.23

0.21

g/l

12.16

1474

15074

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

597

0.90

0.28

2.6

2.7

0.61

mmol/l

0.11

597

(43055514) Macroprolactin [Presence] in Serum or Plasma

376

0.88

0.28

1.3

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

806

1.08

0.27

1.6

2.4

—

(3001729) Color of Synovial fluid

117

0.77

0.27

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

749

1.08

0.27

1.1

166.74

186.30

iu/ml

0.18

740

(3000764) Benzodiazepines [Presence] in Urine

623

6071

1.03

0.26

1.6

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

234

1.15

0.26

2.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

171

0.82

0.26

2.1

3.3

0.71

1.11

mg/l

—

122

(3006598) pH of Arterial cord blood

0.68

0.26

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

628

6125

1.03

0.25

1.6

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

810

0.93

0.25

1.3

1.2

145.03

161.11

mmol/24h

1.29

810

(3028707) Methadone [Presence] in Urine by Screen method

270

2598

1.04

0.25

2.1

2.7

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.20

0.25

1.0

1.1

8.34

8.64

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4116

41499

0.99

0.24

2.3

2.4

2.59

2.78

mg/l

6.14

3387

36056

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

560

1.09

0.24

1.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.18

0.24

1.0

1.1

23.34

20.77

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.18

0.24

1.0

1.1

37.61

36.42

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

191

0.84

0.24

2.0

1.8

1.61

1.71

mg/l

0.10

163

(3009871) Measles virus Ab [Titer] in Serum

694

0.92

0.24

1.7

1.6

3993.85

3309.82

titre

0.30

110

(44813793) Dust mix specific IgE antibody measurement

129

1221

1.06

0.23

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4642

46080

1.01

0.23

2.8

3.1

758.99

1176.13

ng/l

26.13

3804

39687

(46235168) Fasting glucose [Moles/volume] in Blood

180

1.17

0.23

1.1

1.5

6.34

7.00

mmol/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

190

0.84

0.23

1.4

1.2

69.81

67.73

ug/l

0.03

190

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

190

1.16

0.23

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1287

12677

1.02

0.22

3.1

4.0

73.04

88.69

ng/l

14.53

1124

11007

(4281824) Cell count and differential, peritoneal fluid

191

1992

0.96

0.22

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

213

2047

1.04

0.22

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

116

1.21

0.22

1.1

1.0

0.07

0.58

u/ml

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

180

1878

0.96

0.21

1.3

1.2

41.40

30.93

nmol/l

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

39.11

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

17.36

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.09

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

196.73

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.22

0.21

1.2

1.1

26.20

23.16

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.22

0.21

1.2

1.1

38.60

25.02

u/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

616

0.93

0.21

1.4

85.29

220.44

nmol/24h

1.71

616

(3032868) Hemoglobin electrophoresis panel in Blood

145

0.83

0.21

1.7

1.5

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.4

—

84.50

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.5

—

91.50

—

(21494814) CD8 cells/Lymphocytes in Specimen

653

1.07

0.20

1.8

2.1

31.56

31.23

0.07

653

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

82.71

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

463

4743

0.98

0.20

1.7

2.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

992

9765

1.02

0.19

8.1

10.0

24.41

24.28

mmol/l

0.75

965

9601

(3034426) Prothrombin time (PT)

529

1.08

0.19

1.1

1.2

27.21

28.28

1.07

529

(3003577) Lead [Moles/volume] in Blood

133

0.83

0.19

2.3

1.4

0.22

0.16

umol/l

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.23

0.18

1.1

—

22.15

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

251

2433

1.03

0.18

1.1

1.48

1.51

g/l

0.59

227

2218

(40768441) Liver Pathology biopsy report

123

1287

0.96

0.18

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

412

4218

0.98

0.18

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

157

1.15

0.17

1.0

0.03

0.10

u/ml

0.96

101

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

157

1.15

0.17

1.0

1.1

0.02

1.99

u/ml

2.20

126

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.72

0.16

1.0

1.1

1.39

1.28

mom

—

(3009015) Lactate [Moles/volume] in Synovial fluid

186

1.13

0.16

1.5

1.2

5.41

6.40

mmol/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

554

5437

1.02

0.16

1.6

934.48

1013.18

mu/l

1.60

450

4530

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

0.83

0.16

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

194

1877

1.03

0.16

1.2

52.57

64.52

u/l

3.94

174

1638

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

193

0.88

0.15

1.0

1.2

—

(3012898) Urea [Moles/volume] in Urine

172

0.87

0.15

1.4

1.5

260.27

165.76

mmol/l

1.45

153

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.75

0.15

1.0

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

245

0.90

0.15

1.2

102.77

124.14

ng/l

0.17

160

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

245

1.10

0.15

1.9

1.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1060

10727

0.99

0.15

8.4

10.1

1.20

1.33

4.37

1055

10662

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.10

0.15

1.0

1.5

—

(3022229) Phosphate [Moles/volume] in Urine

1.19

0.14

1.3

2.0

14.26

18.22

mmol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

476

4843

0.98

0.13

1.8

2.0

4.07

12.05

iu/l

1.08

153

2006

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

734

1.05

0.13

1.5

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

159

0.88

0.13

1.9

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1884

18696

1.01

0.13

4.8

4.7

232.40

243.23

u/l

3.67

1755

17813

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

335

0.93

0.13

2.1

17.80

16.43

umol/l

0.40

335

(3020393) Adenovirus Ag [Presence] in Stool

161

1.12

0.13

1.1

1.3

—

(3016879) Cocaine [Presence] in Urine

576

5677

1.02

0.12

1.7

2.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

287

1.08

0.12

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

278

2837

0.98

0.11

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.16

0.11

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

621

1.05

0.11

1.9

2.0

477.70

28282.24

u/ml

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.16

0.11

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

509

5022

1.01

0.10

2.2

2.6

3.51

3.59

g/l

0.65

480

4804

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

958

9491

1.01

0.10

2.9

4.4

24.38

24.25

mmol/l

0.89

946

9387

(3037121) Protein [Mass/volume] in Urine

551

5442

1.01

0.10

2.8

3.4

633.14

424.56

mg/l

0.26

216

2447

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8539

85207

1.00

0.10

6.0

6.8

11.25

11.26

umol/l

0.02

8062

81344

(40761995) Spermatozoa Progressive [#/volume] in Semen

300

0.93

0.10

3.7

3.1

49.89

43.82

0.87

300

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

299

0.94

0.09

7.4

6.2

7.32

8.67

0.62

299

(3027944) Amphetamines [Presence] in Urine

609

6026

1.01

0.09

1.6

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

340

3450

0.99

0.09

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

155

1.10

0.09

1.0

0.19

0.67

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

8482

84975

1.00

0.08

3.5

3.9

0.00

estimate

0.02

882

17906

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

765

1.03

0.08

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

765

1.03

0.08

1.4

1.5

—

(3013862) HLA-DP [Type]

1.03

0.07

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.03

0.07

2.7

10.5

98.57

104.94

g/l

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

198

1946

1.02

0.07

3.4

3.6

4.57

12.39

nmol/l

1.21

187

1882

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.81

0.07

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

1312

1.02

0.07

1.2

1.3

1.15

1.80

u/ml

0.79

764

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.03

0.07

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

153

0.91

0.07

5.5

2.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.06

0.07

1.2

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

157

1.08

0.07

1.2

1.1

2.30

1.67

umol/24h

0.38

157

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.12

0.06

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

162

1592

1.02

0.06

2.7

3.3

24.32

13.79

index

0.52

910

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

541

5456

0.99

0.06

3.5

3.4

34.20

43.71

mg/l

0.99

491

4613

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

690

0.97

0.06

1.7

0.85

2.51

u/ml

1.97

184

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

1.09

0.06

1.3

1.2

103.57

111.81

ug/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

829

1.03

0.06

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

699

0.97

0.06

2.9

2.4

51.54

51.94

umol/l

0.04

611

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

415

1.04

0.05

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

951

9462

1.01

0.05

3.2

3.8

52.20

59.56

u/ml

0.21

921

9152

(43055442) Apixaban [Mass/volume] in Serum or Plasma

232

0.95

0.05

1.4

1.6

108.07

114.11

ug/l

0.09

197

(3021387) Prolactin [Units/volume] in Serum or Plasma

532

5356

0.99

0.05

1.6

1.7

268.42

300.55

mu/l

2.61

489

4857

(40765096) Chromosome analysis panel by Banding

496

1.03

0.04

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

500

5029

0.99

0.04

1.3

1.2

178.18

125.99

titre

0.27

481

(3047189) Immunofixation for 24 hour Urine

754

0.98

0.03

1.8

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

101

1024

0.99

0.03

1.5

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

189

0.95

0.03

1.1

1.5

4.12

4.79

nmol/l

0.35

181

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

112

1.07

0.03

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7526

75207

1.00

0.02

2.5

2.8

—

estimate

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

544

5462

1.00

0.02

3.5

36.85

60.18

mg/l

1.61

488

4624

(3050794) Legionella sp Ab [Presence] in Serum

158

0.95

0.02

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

242

1.03

0.02

1.1

1.2

71.24

62.15

ug/l

1.02

242

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

272

1.03

0.02

1.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

890

1.01

0.02

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

113

1.06

0.01

1.0

0.18

0.27

u/ml

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

124

1.05

0.00

1.0

1.1

—

0.23

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

186

0.97

0.00

1.0

—

(44806071) Cardiolipin IgM antibody measurement

229

1.00

0.00

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

140

1.00

0.00

2.1

1.7

39.36

45.18

umol/l

0.46

140

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

472

1.00

0.00

1.7

9.93

9.05

ug/l

0.67

472

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

120

1.00

0.00

1.1

1.2

51.04

43.00

mg/l

—

(3034770) Mitochondria Ab [Titer] in Serum

497

4967

1.00

0.00

1.3

1.2

750.00

994.84

titre

—

155

(3039744) RNA polymerase III Ab [Units/volume] in Serum

141

0.99

0.00

1.1

1.0

—

7.13

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.02

0.00

2.1

2.4

—

(3002619) Bacteria identified in Specimen by Culture

432

1.00

0.00

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

532

1.00

0.00

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

367

1.01

0.00

4.4

3.1

103.94

112.11

ng/l

0.08

158

(40760512) CD34 cells/cells in Bone marrow

0.00

0.0

1.3

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

44.57

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

6.3

—

9.50

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

5.7

—

136.86

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

25.71

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.05

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.90

-0.00

1.5

970.74

483.52

nmol/l

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.90

-0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

0.88

-0.00

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(40760410) HLA-B [Type] by High resolution

0.88

-0.00

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.88

-0.00

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.01

-0.00

1.1

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.90

-0.00

1.0

1.9

2.02

3.63

nmol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.01

-0.00

1.1

8.12

8.29

mmol/l

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

22.91

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SPIROCHAETAL_WIDE – Other spirochaetal diseases, including avohilmo

GWS hits: 4

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other spirochaetal diseases, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other spirochaetal diseases, including avohilmo (AB1_OTHER_SPIROCHAETAL_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints